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ABSTRACT 
 
Traditionally, Sceletium tortuosum has been used as a medicine and for social and spiritual purposes. The 
genus is distributed in the south-western parts of South Africa. This project phytochemically analysed and 
characterised Sceletium plant extracts and determined if any extract showed anti-malarial properties. Extracts 
were prepared in ethanol and methanol and various compounds were purified using column chromatography 
with hexane and ethyl acetate as mobile phase.  The structure of isolated compounds, including mesembrine, 
pinitol, sucrose, mesembrenone and obtusalin, was confirmed using NMR. The Plasmodium Lactate 
dehydrogenase assay was used to screen all extracts and mesembrine to show that four extracts showed anti-
malarial activity with activity values ranging between 1.47 µg/ml and 7.32 µg/ml, well below the 10 µg/ml 
cut off value. The study recommends extracting compounds from fresh plant material and further research as 
to anti-malarial activity of compounds isolated from Sceletium tortuosum. 
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Chapter 1: 
Introduction 
 
1.1 Background 
Globally, there are estimated to be 250 000 plant species including approximately 24 000 species 
that make up South Africa’s rich botanical diversity. Furthermore, about 4 000 plant species are 
used in traditional medicine to remedy different diseases, yet with so much indigenous knowledge 
at our disposal, less than 10% of the world’s biodiversity has been tested for biological activity 
(Harvey, 2000). Natural products (NPs) include plants, animals, marine life and minerals.  They 
have been the basis of treatment of human diseases dating back to the existence of human 
civilization. The use of plants, in particular to control human diseases, is a centuries’ old practice 
that has led to the discovery of more than half of all modern pharmaceuticals (Patwardhan et al., 
2004; Clark, 1996). Indigenous people have sourced medicine and poison from thousands of 
plants.  Unfortunately, many of these systems of medicine have almost completely broken down 
and disappeared, particularly in developed countries and in some developing countries where the 
indigenous population has been marginalized.  These latter countries include many in Africa, where 
indigenous systems have been fragmented along with fragmented tribal and geographical areas 
(Patwardhan et al., 2004). 
 
The medicinal value of plants has been recognized by almost every society worldwide in recent 
years. Most developing countries have relied on, and will continue to rely on, traditional natural 
medicines due to the limiting effect of high costs associated with developing modern allopathic 
medicines. Current estimates indicate that about 80% of people in developing countries still rely for 
their primary healthcare on traditional medicines that are based largely on various species of plants 
(Patwardhan et al., 2004). The science connected with drug discovery is essentially 
multidisciplinary, involving sub-disciplines which include chemistry, pharmacology and clinical 
science. While based on the indigenous use of medicinal plants, the main goal of drug discovery is 
to characterise novel, plant-derived compounds that are biologically active. Clinical, 
pharmacological and chemical studies of traditional medicines derived from plants formed the basis 
of drug discovery a few decades ago.  These include medicines such as aspirin (a), morphine (b), 
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quinine (c), the structures of which are shown in Figure 1 below (Newman, et al., 2000; Butler, 
2004). A recent analysis of a number of NP-derived drugs amongst the total drugs launched from 
1981 to 2002 concluded that NPs were still a significant source of new drugs (Newman et al., 
2003).  
 
CO2H
OAc  
a. Aspirin 
OH
H
NCH3
OH
O
   N
NOH
H
CH2
H
H3CO
 
b. Morphine      c. Quinine 
 
Figure 1: Early medicines predominantly derived from plants (Butler, 2004). 
 
One of the features of NPs is that they provide a greater variety of structural diversity compared to 
that obtained with standard combinatorial, synthetic chemistry. As such, the NP approach offers 
many more opportunities for finding novel, low molecular weight structures that might have 
biological activity against a wide range of assay targets. In general, various compounds that have 
been shown to have activity in bio-assays are usually small molecules capable of being absorbed 
and metabolized by the body (Harvey, 2000). Over the past few decades, NPs have featured 
extensively in the chemotherapy of parasitic diseases, particularly where quinine, emetine and 
berberine were used to treat malaria, amoebiasis and leishmaniasis, respectively, while santonin 
was used to treat helminthic infections.  In addition, with the discovery by Chinese scientists in the 
early 1970s, of artemisinin, an antimalarial component contained in the plant Artemisia annua, 
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attention was rekindled regarding the potential source of plant extract products to treat an 
assortment of parasitic diseases (Croft, 2001). 
 
It is common knowledge that medicine and NPs have been closely linked through the use of 
traditional medicine and natural poisons over the years.  However, even with this knowledge, many 
more plant species are awaiting analysis for NP discovery (Butler, 2004). Natural products are the 
most consistently successful sources of drug leads, but despite this their use in drug discovery has 
fallen out of favour. As mentioned above, less than 10% of the world’s biodiversity has been tested 
for biological activity and, thus, many more useful natural lead compounds are awaiting discovery, 
and the challenge facing scientists is how to access and harness this natural chemical diversity 
(Harvey, 2000). Although traditionally NPs have played an important role in drug discovery, in the 
past few years most multinational pharmaceutical companies have either terminated or 
considerably scaled down their natural product operations (Butler, 2004). This shows that despite 
the success of natural products in drug discovery, there is still little belief in the power of this 
indigenous knowledge. However, NPs are still providing their fair share of new clinical candidates 
and drugs despite the development of highly competitive drug discovery methods in the industry 
(Newman et al., 2003).  
 
The Sceletium genus is amongst taxa that have been extensively researched, but never in terms of 
an anti-malarial drug. The genus is distributed in the south-western parts of South Africa and has 
an affinity for arid environments. Traditionally, plants of the genus Sceletium 
(Mesembryanthemaceae) have been used to relieve thirst and hunger, to combat fatigue, as 
medicines and for social and spiritual purposes by San hunter-gatherers and Khoi pastoralists 
(Gericke and Viljoen, 2008). Although most of the traditional uses have been scientifically 
validated, this plant may offer up many more NPs. Malaria is one of the world’s most deadly 
infectious diseases and continues to be associated with a considerable burden of disease and 
death and thus, has a significant social and economic impact on developing countries and societies 
(Alshawsh et al., 2007). An increasingly serious problem associated with malaria parasites, is the 
development of resistance to quinoline-containing drugs, such as chloroquine, making the disease 
a serious worldwide health problem (Kaur et al., 2009; Gelb, 2007). Individuals must take anti-
malarial drugs as prophylaxis about one to two weeks before travelling to a malaria-infested area 
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and for four weeks after leaving the area. Travellers are advised by Centres for Disease Control 
(CDC) to avoid malarial outbreak areas. Wearing appropriate clothing is very important in 
minimizing skin exposure. Where there is no adequate air conditioning or accommodation is not 
adequately screened, bed nets are a necessity to provide protection. Bed nets are most effective 
when they are treated with an insecticide or repellent such as permethrin. Insecticides can help to 
clear rooms or areas of mosquitoes, but optimum protection can be provided by applying repellents 
containing at least up to 50% N,N-diethyl-m-toluamide (DEET) and not more than 10% for children 
(www.doh.gov.za/docs/policy/2011/malaria_prevention.pdf). 
 
NCl
NH
CH3
N CH3
CH3
 
 
Figure 2: Structure of chloroquine (Read et al., www.bank.ca/drugs/DB00608) 
 
Africa is amongst several continents that are significantly affected by drug-resistant malarial 
parasites and this is reflected in the doubling of malaria-attributable child mortality in Southern 
Africa (White, 2004). It is a developing continent that is neither well established nor equipped for 
this battle. In reality, most malaria cases occur in remote areas, where adequate resources are 
limited, if not completely unavailable (Hommel, 2008). This infection could cripple some of these 
developing countries and continent’s economy, especially in Africa where approximately 50% (if 
not more) of its current population is poverty stricken (Wanjala, 2008). Resistance to all known anti-
malarial drugs (i.e. multidrug resistance (MDR) or extreme drug resistance (XDR) has developed to 
various degrees in several countries.  Thus, there is an urgent need to counteract MDR/XDR 
malaria strains by developing new classes or compounds of anti-malarials (Bloland, 2001). While 
many countries and their populations still rely on traditional medicine as a resource for the 
treatment of this disease, there is reason enough to support studies of combined traditional 
medicine with the western approach of scientific research and technology to produce a reliable 
anti-malarial drug.  
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1.2 Problem statement 
Even with competition from other drug discovery methods, natural products still provide new clinical 
candidates and drugs (Newman et al., 2003). The chemistry and pharmacology of many of these 
medicinal plants, such as Sceletium tortuosum, have not yet been thoroughly investigated. South 
Africa can benefit from the scientific evaluation of this indigenous plant and its knowledge base 
(Harvey, 2000). With alkaloids being one of the most important classes of natural products 
providing drugs since ancient times (Kaur et al., 2009), this study will focus on the chemical 
characterisation, together with some biological evaluation, of substances isolated from Sceletium 
tortuosum. 
 
1.3 Aims and Objectives 
1.3.1 Aim of the study: 
To perform phytochemical analysis of extracts of Sceletium tortuosum in order to characterise 
secondary metabolites and also to evaluate these together with crude extracts and fractions for 
anti-malarial activity. 
 
1.3.2 Objectives: 
• To scientifically investigate the traditional extraction method from Sceletium tortuosum (S. 
tortuosum) plant material. 
• To phytochemically isolate secondary metabolites from S. tortuosum extracts. 
• To process and structurally elucidate compounds from S. tortuosum extract, using Nuclear 
Magnetic Resonance (NMR) and High Performance Liquid Chromatography Mass 
Spectrometry (HPLC-MS).  
• To profile and compare different extracts from S. tortuosum using HPLC-MS. 
• To screen extracts from S. tortuosum for biological activity using an anti-malarial assay 
system. 
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Chapter 2 
Literature review 
 
2.1 Introduction 
The mesembryanthemaceae (leaf succulent plants) are one of the largest succulent plant families 
constituting a major part of the South African succulent flora. This family is almost exclusively 
confined to southern Africa, with less than 2% of the species occurring naturally outside this region. 
The family is sometimes included in the Aizoaceae group and the family name commonly used in 
several articles is Mesembryanthemaceae Fenzl. Within this group, the Mesembryanthemaceae 
family is the second largest family, with approximately 2000 species and 116 genera, but more 
than three-quarters of its species have never been studied (Chesselet et al., 1995; Ihlenfeldt, 
1994). Originally, all species of this family were united in a single genus Mesembryanthemum L., 
as proposed by Breyne in 1689 in Ihlenfeldt (1994). With the growing number of known species, it 
became necessary to split this genus and several attempts using mainly life-form characters were 
made (Ihlenfeldt, 1994). The word Mesembryanthemum originates from the name ‘midday flower’, 
which refers to the opening of the flowers around noon. Other common names include ice plant, 
fig-marigold, iqina (Xhosa) and mesemb. Plants that belong to the Mesembryanthemaceae family 
are known by most South Africans as vygies (Chesselet et al., 2002). 
 
The genus Sceletium N.E. Br. is classified under the family Mesembryanthemaceae (Aizoaceae) 
and belongs to the sub-family Mesembryanthemoideae (Patnala and Kanfer, 2009; Smith et al., 
1996). The genus name is derived from the word ‘sceletus’ which means ‘skeleton’, referring to the 
prominent vein-like lines (See Figure 2.1 below) which are most easily visible in the old, dry and 
withered leaves (Gericke and Viljoen, 2008). Of the twenty two Sceletium species described by 
Brown (1926) in Gericke and Viljoen, (2008), eight species are currently recognized i.e. Sceletium 
crassicaule (Haw.) L. Bolus, S. emarcidum (Thunb.) L. Bolus ex H.J. Jacobson, S. exalatum 
Gerbaulet, S. expansum (L.) L. Bolus, S.rigidum, L. Bolus, S.strictum, L. Bolus, S. tortuosum and 
S. varians (Haw.) Gerbaulet (Smith et al., 1998).  Of the eight, only S. tortuosum is well known and 
is used in commercial herbal products (Van Wyk and Wink, 2004). 
  
Figure 2.1: Sceletium leaves showing the distinctive idioblasts on the leaf surface and the characteristic 
skeletonised old leaves (Gericke and Viljoen, 2008).
 
The general application of Sceletium
revised by various authors since the genus was established in 1925 by N.E. Brown. This group of 
plants is characterised by the skeletonised leaf venation pattern visible in dried leaves. In 1986, 
Bittrich argued for a broader application of 
subgenera (Gericke and Viljoen, 2008
synapomorphy (a unique derived character) for Bittrich’s broad concept of 
reinstated Sceletium as a genus (Gericke and Viljoen, 2008). 
distinguished on the basis of vegetative, flower, fruit and seed characteristics. 
reduced to synonymy including Sceletium
considered part of S. tortuosum. 
characteristic succulent leaves with “bladder cells” or idioblasts
from white, yellow to pale pink. These plants were commonly known by their vernacular names 
which include kanna (Khoi) and kougoed
material by chewing (Gericke and Viljoen, 2008).
 
 
 (Aizoaceae, subfamily Mesembryanthemoideae) had been 
Phyllobolus which included Sceletium
). Since Gerbaulet (1996) was unable to find a 
Species of this genus are 
 joubertii L. Bol., and S. namaquense
Sceletium exhibits a climbing or decumbent habit and ha
 (Figure 2.1)
 (Afrikaans), the latter referring to the use of the plant 
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 as one of five 
Phyllobolus, she 
Some species are 
 L. Bol. now 
s 
. The flowers range 
  
Figure 2.2: Representative of the characteristics mentioned in the above paragraph (Gericke and Viljoen, 2008).
 
Kougoed usually grows hidden under other bushes, but it occasional
small size of seeds is adapted for wind dispersal, 
will grow. The plant occurs in winter
months, when the growing season
still retains its activity when it is green, but a lot of its 
plant (Gericke and Viljoen, 2008). 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3: Geographical distribution of 
 
ly grows out
whereupon landing in a suitable area, the plant 
 rainfall areas (Figure 2.3) and is at its best in 
 is over and the leaves appear yellowish and wilted. The plant 
vigour is lost through fluid
Sceletium in South Africa (Gericke and Viljoen, 2008)
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 in the open. The 
the summer 
 that drains from the 
 
  
2.2 Traditional preparation, dosage and uses
One of the co-authors in Smith et al
plants using traditional methods of preparation 
historically, a skin or canvas bag was used as a fermentation vessel, but that these have been 
replaced by plastic bags (Smith et al.,
material is crushed in the plastic bag between two stones
crushed ‘”kougoed” is then left in direct
its contents re-mixed and then the bag is tightly closed again. The bag is opened on
after which the crushed. kougoed 
claimed that eating fresh plant is not beneficial
therefore, one must follow the whole 
(Smith et al., 1996; Gericke and Viljoen, 2008
 
 
 
 
 
 
 
 
 
Figure 2.4: Dried fermented plant material ready for use (Van Wyk and Wink, 2004).
 
Traditionally, the fermented and dried herb is chewed
also be used as a tea, decoction or 
either in tablet and capsule form, also
three times a day. Sceletium tortuosum
anxiety, stress and tension. Decoctions of this herb have
infants, as well as forming part of 
hypnotic and sedative properties have also been attributed to this plant
 
 
., (1996) undertook a field trip to Namaqualand 
for commercial re-sale. An informant reported that 
 1996). According to this method of preparation, w
, after which the tightly sealed bag of 
 sunlight to ferment. The bag is then opened after 2
is spread out to dry in the sun, as shown in 
 (as the plant doesn’t have powers in its fresh form
process of fermentation to unlock powers 
; Patnala and Kanfer, 2009). 
, hence, the Afrikaans name
tincture. A dose of 100-200 mg of the dried powdered herb
 contains around 1-4 mg of alkaloids,  
 can be used as a mood enhancer, as well as
 reportedly been used 
replacement therapy for alcoholics, where
. The apparent absence of 
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to collect these 
hole plant 
-3 days, 
 the eighth day, 
Figure 2.4. It is 
); 
from the plant 
 
 “kougoed”. It can 
, 
can be taken two or 
 to counteract 
to treat colic in 
, therapeutically, 
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physical and psychological dependency, even after many years of habitual use, is one of the 
interesting features of this unique plant. There has not been a single record of any negative side 
effects arising out of using material from this plant, although it has been reported that high doses 
may cause euphoria, although the plant is not hallucinogenic (Van Wyk and Wink, 2004). 
 
2.3 General background on the chemistry of alkaloids 
For over 4 000 years, humans have used drugs such as medicine, potions, teas and poison that 
have since been determined to contain alkaloids. Alkaloids are diverse, secondary compounds 
derived from amino acids. These compounds are classified according to the amino acids that 
provide their nitrogen atom and part of their carbon skeleton. As such, alkaloids are not the end 
product of metabolism but can be degraded to serve as a nitrogen source when needed. Purine 
alkaloids are the ones most commonly ingested as a daily dose acquired in a cup of tea or coffee 
(Aniszewski 2007; van Wyk et al., 2008). In general, alkaloids are bitter tasting, white solids, with 
nicotine being an exception, occurring as it does as a brown liquid. There are three main types of 
alkaloids: true alkaloids, proto-alkaloids and pseudo-alkaloids. True alkaloids form water-soluble 
salts mostly occurring as well-defined crystalline substances. In addition, these compounds have 
decarboxylated amino acids that are condensed with a non-nitrogenous structural moiety occurring 
in limited number of species and families. In the class “pro-alkaloids”, however, there is an 
exception for those amine compounds, like the mescaline amines, that have a nitrogen atom 
placed in a ring structure (Robinson, 1974).  Although proto alkaloids do not have a heterocyclic 
ring containing a nitrogen atom, they are, nevertheless, also derived from amino acid sources. 
These alkaloids have a very simple structure with closed rings and are considered a minority group 
amongst the alkaloids. Pseudo alkaloids contain a heterocyclic ring with nitrogen, but their basic 
carbon skeletons are not derived from amino acids. These alkaloids are connected to amino acid 
pathways being derived from the precursors, or postcursors, of amino acids and of non-amino acid 
precursors (Aniszweski, 2007; Cherney and Baran, 2011). Alkaloids can be classified in terms of 
their biological activity, chemical structure (nucleus-containing nitrogen) and by their biosynthetic 
pathway (Roberts & Wink 1998; Hegnauer, 1988).  
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2.3.1 Chemistry of alkaloids applied to the genus Sceletium 
Van Wyk and Wink (2004) have indicated that alkaloid toxicity and pharmacological activity in 
animals and humans appears to correlate with interactions involving particular molecular targets. 
Alkaloids are undoubtedly multipurpose compounds that, depending on the situation, may be 
variously active, e.g. as defence compounds against herbivorous animals, bacteria, fungi, viruses 
or competing plants. Knowledge of alkaloidal variation in plants is important in the production of 
plant medicine, because it allows the plant to be collected and harvested at the right time and the 
right growth stage (Van Wyk and Wink, 2004).It is believed that the phytochemical exploration of 
the genus Sceletium commenced in 1898 when Meiring isolated a crude alkaloid mixture from 
Sceletium tortuosum. This was followed by the work of Zwicky in 1914 who apparently isolated 
several alkaloids including mesembrine and mesembrenine (Gericke and Viljoen, 2008). It was 
suggested that mesembrine isolated by Zwicky was not pure, meaning that the molecular formula 
(C16H19NO4N) that was first proposed was incorrect. The correct formula (C17H23NO3) was later 
confirmed in the early 1960’s by the well-known German pharmaceutical company C.F. Boehringer 
and Soehne, and also by S.B. Penick in New York (Gericke and Viljoen, 2008).  
 
The number of Sceletium species within the Aizoaceae family that have been examined for the 
presence of alkaloids has been restricted by their geographical inaccessibility. Within the Sceletium 
genus, a number of alkaloids are produced which mainly belong to the crinane class of 
compounds. The structure of four different alkaloids are indicated in Figure 2.5 (a to d): (a) the 2a-
aryl-cis-octahydroindole class (e.g. mesembrine), (b) the ring C-secomesembrine alkaloids (e.g. 
joubertiamine), (c) a tetracyclic pyridine alkaloid class with only two reported members, (e.g. 
Sceletium alkaloid A4), and (d) a ring C-secoSceletium alkaloid A4 (tortuosamine) (Jeffs et al., 
1982). 
 
N
OCH3
OCH3
O
CH3     
N
OH
O
CH3 CH3  
a. Mesembrine b. Joubertiamine 
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Figure2.5: Structure of alkaloids from the genus Sceletium (Jeffs, 1982). 
 
2.4 Phytochemistry: 
Phytochemistry is the study of the chemical makeup of medicinal plants (Saroya, 2011) and, being 
a sub-discipline founded on both organic as well as biochemistry, focuses on the extraction and 
subsequent characterisation of phytochemical entities that have been used by herbalists, but with 
an added dimension of employing a number of chromatographic techniques to isolate pure 
compounds for structural elucidation and pharmacological testing (Macías et al., 2007).This sub-
discipline also plays a fundamental role as an analytical technique for quality control and 
standardisation of phytotherapeuticals.  Column chromatography (CC) was introduced at the 
beginning of the twentieth century to separate plant pigments and is now routinely used to separate 
various compounds (targeted and non-targeted, polar or non-polar) from any plant extraction of 
choice (Ettre, 2003). Thin layer chromatography (TLC) offers the option of presenting the result as 
a series of banded images which can be photographed, particularly under UV light, and is an ideal 
screening method for biological and chemical analysis. In general, the TLC methodology provides 
for chemical identification with either qualitative or quantitative results, or just with semi-quantitative 
determination (Marston, 2007). 
 
2.5 Nuclear Magnetic Resonance (NMR) 
Nuclear magnetic resonance (NMR) is a highly versatile, chemically non-destructive tool used in 
analytical chemistry to determine, amongst other things, content and purity of a sample (Moco et 
c. Sceletium alkaloid A4 d. Tortuosamine 
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al., 2007). In addition, this technique allows for the investigation of structural and dynamic aspects 
of macromolecules (Griesinger et al., 2012). As such, NMR analysis provides an added benefit of 
being able to accommodate quality control tracking of sample preparation process methodologies. 
As such, NMR analysis is considered to be one of the most powerful techniques for solution 
conformational analysis of organic (and inorganic) compounds and bio-macromolecules. NMR 
spectroscopy, thus, gives detailed information about molecules and their environment based on the 
interaction of nuclear magnetic moments with electromagnetic radiation (Corcoran and Spraul, 
2003). In essence, sample material from fractionated extracts derived from plant material can be 
analyzed when the material is placed in a strong magnetic field and irradiated with radio waves to 
cause the entire proton (1H) and carbon 13 (13C) nuclei to occupy the higher energy – 1/2states. As 
the nuclei in the sample material preparation relax back to the + 1/2 state, they release radio waves 
corresponding to the energy of the difference between the two spin states. The radio waves are 
recorded and analyzed by computer to give intensity versus frequency plot of the sample. This 
information can then be used to determine the structure of various compounds present in the 
sample material (Havsteen, 2002). 
 
2.6 Malaria Bioassay 
2.6.1 Bioassay approach to screen for biological activity of various compounds isolated 
from S tortuosum. 
It is not a norm to have reports on the medicinal plant use as a key source of health care. It is 
reported that 80% of the world’s population relies on traditional herbs for wellness and reliable 
health care source. A further estimated 80% of Africans are said to rely on traditional remedies 
(Karunamoorthi and Tsehaye, 2012). An elevated prevalence of malaria as a disease and its 
parasitic resistance to treatments resulted in the search for novel anti-malarial compounds from 
plants used in traditional medicine (Bero et al., 2009). Twelve different plants were gathered, 
extracted and evaluated for their anti-plasmodial activity in vitro against a chloroquine-sensitive 
strain of Plasmodium falciparum 3D7 and the Plasmodium lactate dehydrogenase (pLDH) 
technique was used to measure parasite viability according to the method described by Makler et 
al., (1998). Some of the plants screened in this study included Papalialappacea, 
Byrsocarpuscoccines, Trichilia emetic and Acanthospermumhispidum. The J774 macrophage-like 
murine cells, W138 human normal fibroblast cells, W2 chloroquine resistant strain of pLDH were 
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also assayed for both cytotoxicity, and anti-plasmodial activity. From this study, Bero and 
colleagues (2009) found that out of the 42 extracts yielded from the 12 plants, 5 were considered 
effective with IC50 values ≤20 µl/ml. Most extracts were considered not to be toxic. Only two 
extracts extracted with dichloromethane were found to be toxic (Bero et al., 2009). A similar study, 
where 170 plant species reported to be commonly used as traditional medicine for various 
pharmacological properties including anti-parasitic activities, was undertaken on indole alkaloid-
containing plants possessing anti-plasmodial and cytotoxic activities (Girardot et al., 2012). 
Anthropologically based studies on plant usage to treat malaria have also been undertaken as 
described by Stangeland et al., (2011). 
 
2.6.2 Malaria Rapid Diagnostic Tests (RDTs) 
The in vitro diagnostic assay is based on the specific detection of Plasmodium Lactate 
DeHydrogenase (pLDH) activity. This assay exploits a panel of monoclonal antibodies that capture 
the parasite enzyme and allow for the quantitation and species identification of human malaria 
infection. The pLDH enzyme is produced by live parasites and is easily detectable when they are in 
late trophozoite and schizont phase. Based on the detection of this enzyme, relative drug 
resistance and activity can also be detected for all human Plasmodium infections (Piper et al., 
1999). 
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Chapter 3 
Research Methodology: Part A 
 
3.1. Plant collection and initial extraction protocols 
3.1.1 Plant collection 
Nineteen kg of Sceletium plant material was harvested on 11 – 12 June 2009 under sunny and dry 
conditions at Kamieskroon in the Northern Cape of South Africa. The plant material was supplied to 
the Council for Scientific and Industrial Research (CSIR) for this study by Enterprise Creation for 
Development (ECD) and collected by Mr Jonny Burger, an independent botanist. This study 
required harvesting of whole plant material by the supplier. The mass of the plant material thus 
supplied depended on the availability of the plants themselves. Plant material was submitted to the 
South African National Biodiversity Institute for positive identification and confirmation. The plant 
material was identified as Sceletium tortuosum N.E. Br. Storage, transportation and handling were 
carried out by following standard operating procedures to allow the material to be used in product 
development. 
 
A few months before the study ended, Parceval supplied two batches of dried, ground plant 
material to the CSIR for the stability test required for this study. It is not known if they were 
harvested at the same time or place. The first batch was ground, but could be visibly identified as 
Sceletium species (spp.). The total mass supplied and used was 1.280 kg. The second batch, 
although not ground to a fine powder, could not visibly be identified as Sceletium spp. and because 
of this, extractions and experiments on this batch of plant material were carried out separately. The 
original mass received was 2.423 kg, but only 0.423 kg was used for this study and the rest was 
used by CSIR researchers for an independent study.  
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3.1.2 Ethical consideration 
Permission to carry out this study was requested from the Research and Ethics Committee of The 
University of South Africa (UNISA) (Muckleneuk campus). Accompanying the application form were 
copies of: the Bio-risk assessment Bioprospecting CSIR research check list; the Harvesting of plant 
material certificate; the plant identification certificate issued by South African National Biodiversity 
Institute (SANBI) and the research proposal. Permission was granted by the UNISA Research and 
Ethics Committee.  In terms of CSIR regulations, a Research Ethics check list was used to identify 
whether a full application for ethics approval needed to be submitted before the work commenced - 
according to the check list this was deemed not to be necessary. 
 
3.2 Plant preparation and extraction 
3.2.1 Plant preparation 
The experimental process was divided into 3 groups designed to accommodate:- 
• freeze drying of wet plant material; 
• fermentation in a conventional oven at 35oC under natural conditions and;  
• drying plant material in a conventional oven at 60oC. 
 
From the 19.8 kg of plant material received, 10 kg of fresh Sceletium tortuosum plant material was 
retained at -20oC, while the remaining 9.8 kg was used for the experiment. The experimental stock 
was divided into 14 batches of 250 g each and the remaining material of 6.3 kg was placed in a 
60oC oven to dry. The dry plant material was not ground to a fine powder, but was broken and 
crushed into smaller pieces. The first 250 g of plant material was crushed and extracted on the day 
of arrival. The second 250 g was placed at -20oC and then freeze dried the following day. After 6 
months, from the 10 kg of specimen that had been stored at -20oC, 250g was weighed out and 
then freeze-dried for approximately 36 hrs. After freeze drying, the plant material was crushed and 
broken into smaller pieces. 
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3.2.1.1 Extraction 
Plant material was transferred to 1000 ml glass beakers (Schott-Duran, Germany). Two magnetic 
stirrers and sufficient ethanol solvent (96% Rectified A.R., Radchem, E1315X) was added to cover 
the plant material which was placed into each beaker during the extraction process. The mixture 
was covered tightly with a piece of aluminium foil  before being placed on a stirring heating plate 
(Labotec, Heidolph, MR 3002) and heated at 40oC for 2 days (48 hrs). The temperature was 
monitored throughout the extraction process with a mercury thermometer. After extraction, the 
contents were mixed thoroughly and then filtered through filter paper into a 1000 ml conical flask 
connected to a vacuum pump (KnF Neuberger, Laboport). The extract was filtered twice to remove 
any debris remaining in the suspension. The ethanol in the filtrate was evaporated at 45oC (Med + 
low BP Mixture) using the GeneVac® Personal evaporator.  
 
The following step applies only to the last sample mentioned in plant preparation part A. Following 
evaporation of the ethanol, 100 ml of water was added to the dry extract that was then dissolved 
and freeze dried. From the dry plant material, 2.3 kg was extracted in the same manner as above. 
For the remaining 4 kg, the same method was followed as described above, but only in this case 
chemically pure (CP) grade methanol (Merck, RSA) was used as the solvent of choice. 
 
3.2.2 Plant preparation - Fermentation 
Of the 12 remaining experimental 250 g samples, 2 x 250 g was prepared for 7 days’ fermentation 
under natural conditions. The first 250 g was placed in a thermal plastic bag and tightly sealed, 
while the duplicate 250 g amount was placed in an open aluminium tray. These samples were 
crushed and placed under direct sunlight and left for seven days. On the third day of the 
experiment, the plant material was thoroughly mixed, re-sealed and left to further ferment till the 
seven days had elapsed. The following process was used for the remaining 10 x 250 g samples.  
Of these, 5 x 250 g amounts were placed in thermal plastic bags that were then sealed and 
labelled as follows: Day 2 (48 hrs), Day 4 (96 hrs), Day 6 (144 hrs), Day 8 (192 hrs) and Day 10 
(240hrs).  Additional duplicates were prepared with the remaining 5 x 250 g amounts that were 
placed in aluminium open trays and labelled appropriately. While in the baggage state, plant 
material was crushed and subsequently placed in an oven for fermentation at 35oC, for an 
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appropriate period specified on the labels. In parallel, but only after 6 months had elapsed, 4 kg of 
the original plant material stored at-20oC, was divided into 10 x 400 g. The method of fermentation 
described above was subsequently followed for these new samples. To better understand the 
process above, please view Figure 3.1 and Figure 3.2 on pages 28-29. 
 
3.2.2.1 Extraction of Fermentation Products 
After 2 days of fermentation, the samples labelled Day 2 (A - thermal bag) and (B - open tray) were 
removed from the oven and transferred to 1800 ml glass beakers for extraction. Two magnetic 
stirrers were placed in the beakers, one was placed at the bottom of the beaker under the plant 
material and the other stirrer was placed on top of the plant material. Approximately 600 ml of 96% 
Rectified Ethanol (A.R.) was poured into the beakers to cover the plant material which was then 
tightly covered with a piece of aluminium foil. The beakers were then placed on a stirring heating 
plate that was adjusted to 40oC and set at 1250 revolutions per min (rpm) for the duration of the 
extraction process. The plant material in the two beakers was extracted for 2 days (48 hrs). During 
this extraction period, the plant material was manually stirred and crushed, while the temperature 
was monitored with a mercury thermometer. Following extraction, the contents were thoroughly 
mixed before being filtered through a clean paper filter into a 1000 ml conical flask. The extracts 
were filtered twice to remove any debris remaining in the suspension. Filtrates were evaporated at 
45oC (Med + low BP Mixture) using the GeneVac® Personal evaporator connected to a vacuum 
pump (KnF Neuberger, Laboport).Of the 4 kg fermented plant extraction that was carried out 6 
months after the initial fermentation process, the following steps were added to the process 
described above. Specifically, filtered suspensions were further divided into two equal volumes 
before solvent evaporation. After the ethanol was evaporated, one of the dry extracts was 
dissolved in 100 ml of water and freeze dried. The other dry extract was dissolved in methanol and 
evaporated at 45oC using the rotary vacuum evaporating system, after which it was stored at 4oC. 
Apart from these additional steps, the extraction processes for both stored and directly extracted 
sample lots were identical. 
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3.2.3 Parceval plant extraction 
Parceval dried plant material was extracted with ethanol according to the extraction process 
described in section 3.2.2, except that this extraction took place at room temperature. These 
extracts were stirred continuously and temperature was monitored throughout the process. 
Concentration/evaporation was also carried out as described in section 3.2.2, but none of the 
extracts were freeze dried. These extracts were labelled as follows: SCE-187-46311 and SCE-187-
46312.1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                          
1
 To further describe the processes mentioned above, the fermentation processes are shown in Figure 3.1 and 3.2. Figure 3.1 
summarizes extraction of all samples from the initial 9.8 kg plant material, while figure 3.2 summarizes extraction process of the 
4.25 kg sample that had been stored for 6 months at -20
o
C. 
  
Figure 3.1: Extraction process followed for 
                                                          
2
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Chapter 3 (Continued) 
Research Methodology: Part B 
 
3.3 Chemical analysis: 
3.3.1 Chromatography 
3.3.1.1 High Performance Liquid Chromatography (HPLC) 
The word ‘chromatography’ was originally applied to a process to separate coloured 
(chromatogram) chemical entities via differential migration through an immobile (stationary phase) 
using a suitable solvent (the mobile phase). When the migration is in a liquid phase, percolating 
through a column filled with a stationary material, the technique is called liquid chromatography 
(LC). The stationary phase can be an adsorbent or a liquid-impregnated adsorbent. The mobile 
phase is a liquid. When the mobile phase is under increased hydraulic pressure, this allows for 
more efficient column separation of closely sized/electronically charged sample components and 
LC is referred to as high pressure liquid chromatography (HPLC). Efficiency of HPLC is expressed 
in the reduced plate height form and can be obtained with similar particles and, therefore, higher 
pumping pressures and by using good column technology. Thus, it can be argued that HPLC is 
that form of chromatography when high pressure is applied, regardless of efficiency (Verzele and 
Dewaele, 1986). 
 
On a chromatogram, the peaks are recorded on a time axis from the time that the sample is 
introduced into the column. The peaks are represented in a form of a (quasi) Gaussian curve. The 
mean time, at the maximum of this curve that a peak spends in the column, is the retention time for 
the compound (tR/Rt). When reporting or referring to a peak, its Rt is important to state as different 
compounds elute at different times due to, for example, the difference in molecular masses. The Rt 
is what makes it easy to distinguish between two different compounds, although it is possible to 
find two different compounds eluting or presenting with the same Rt. Retention time is usually 
displayed at the top of every peak in the chromatogram, but it can be calculated using the following 
formulae tR = to (1=k’) where to is the “hold up” time of the column where non-retained and non-
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adsorbed molecules are eluted; and k’ is the ratio of the concentrations, weight or number of moles 
in the two phases of the chromatographic two phase system (Verzele and Dewaele, 1986). 
 
High performance liquid chromatography (HPLC) is used routinely in phytochemistry to pilot the 
preparative isolation of natural products. Essentially, this involves the optimization of the 
experimental conditions by paying particular attention to the consistency of the yield of different 
fractions throughout the separation, in order to control the final purity of the isolated compounds 
(Marston, 2007). Other chromatographic techniques employed in the purification of fractions and 
crude extracts during this study included flash chromatography (FC), column chromatography 
(CC), TLC, preparative-TLC and use of the chromatotron. Depending on the complexity of the 
crude extract or fraction being purified, CC employed different column sizes ranging between 11 – 
60 cm in length and 1.5 - 6 cm in diameter with, 10 - 1000 ml capacity.  Silica gel 60 (particle size 
ranging from 0.063 – 0.2 mm, 70 – 230 mesh ASTM) (Sigma – Aldrich Logistic GmbH) was used 
as a stationary phase. Monitoring of the progress of the CC technique was done by using 0.2 mm 
thick silica pre-coated TLC aluminium or glass plates (F254 UV active) viewed under short (254 nm) 
and long (365 nm) wavelength ultraviolet fluorescence within an analysis cabinet (Spectroline 
model CM-10, Spectronics corporation, Westbury, New York U.S.A). 
 
3.3.1.2 Isolation and purification of compound 1 
Approximately 2 g of ethanol (EtOH) extract was weighed (Sartorius AG GİTTINGEN weighing 
instrument, Max 200 g – d=0.1 mg, Germany) and dissolved in 10 ml of methanol (MeOH), 
sufficient to cover and dissolve the extract. Sufficient silica gel was added to the suspension and 
the solvent was evaporated. A flash column was prepared as follows: silica 60 was mixed in 
chloroform (CHCl3, CP Grade, Merck, RSA), sufficient to create a mobile phase for column 
packing, and then poured into the 500 ml column whose base was blocked with a cotton wool plug 
that allowed the solvent to flow but prevented silica from escaping with the solvent. The excess 
solvent was removed from the column until just about 20 ml remained above the silica (this method 
of preparation was applied to all columns). The solvent was allowed to run out of the column to just 
above the silica bed before the sample was loaded on top of the prepared column filled with silica 
gel before eluting (the volume of the silica gel differed according to the size of the column being 
used. This was then covered with a thick layer of cotton wool to prevent disturbance and layer 
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distortion when adding the solvent. Solvent systems used were CHCl3/MeOH 9:1, CHCl3/MeOH 8:2 
and CHCl3/MeOH 7:3 and finally 100% MeOH.  Twelve fractions of between 300 – 400 ml were 
collected into 500 ml Erlenmeyer flasks. These were placed in the fume hood to evaporate the 
solvent. When spotting on TLC plates, the fractions were dissolved with 1 ml MeOH. The plates 
were run in 9:1 CHCl3/MeOH. 
 
Compound 1: 
Fraction 7 indicated that it was a suitable fraction for further purification. This was as a result after 
spraying the TLC plate with the spray reagent and target compounds were identified in large 
quantities in this fraction. Since alkaloids were compounds being targeted, a spray reagent that 
could react with nitrogen- or amine-containing compounds was essential. Ninhydrin (2.2-
dihydroxyindan - 1,3-dione, C9H6O4, Merck, RSA) was used to spray all plates in this experiment. A 
second column was run with the same solvent systems as the first column and 35 fractions were 
collected. Fractions 2 – 21 were combined, evaporated and purified using preparative TLC (Prep-
TLC) using the same solvent as above.  
 
3.3.1.3 Isolation and purification of compounds 2 and 3 
Approximately 5 g of methanol extract (sample no. SCE-187-46222) was weighed out and 
dissolved in methanol (MeOH CP grade, Merck, RSA). Silica gel 60 (particle size ranging from 
0.063 – 0.2 mm, 70 – 230 mesh ASTM) (Sigma – Aldrich Logistic GmbH) was added to the 
suspension and the solvent subsequently evaporated. A gravity column (with reference to that 
described in section 3.3.2.1) was then prepared and fractions eluted with CHCl3/MeOH (9.5:0.5).  
Fractions of about 50 ml were collected into 100 ml bottles. Solvent ratios were increased by 0.5% 
MeOH after every 1 L of solvent system used. The results of the TLC were used as an additional 
guide line to determine solvent system change. When spotting a fraction on TLC, one or several 
constituents may elute at different retention times (the distance at which the compound has 
travelled along the plate when exposed to a solvent system). In a serial fashion, when no more 
constituents are detectable, either UV positive or non-UV positive, the solvent system is changed 
and the polarity increased to elute more polar compounds than those previously isolated. A total of 
497 of the 50 ml fractions were collected, concentrated and dissolved in 1 ml methanol. The 
fractions were spotted on TLC plates and resolved with CHCl3/MeOH (8:2). Since there were many 
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fractions collected, many samples were combined, based on the similarities portrayed on the TLC 
plates. The 18 new fraction combinations were named group A – R. Forty eight hours after the 
column was completed, all new groups were dissolved in methanol and crystals were observed in a 
few of the vials from fraction I - N. Crystals observed in fraction I through to fraction K looked 
similar in colour, texture and morphology and these crystals were different from those noted in 
fractions L and M. 
 
Compound 2: 
Crystals formed in fractions K, L and M were combined and washed with methanol. As they did not 
dissolve in MeOH, dimethylsulfoxide (DMSO) was used to dissolve the crystal in preparation for 
TLC spotting. The solvent system used to run the plates was acetone, butanol, H2O and acetic acid 
(40:10:5:1). As these  compounds were found to be non-UV active, they were provisionally 
assumed to be a sugar connected to a nitrogen-containing compound, and subsequently sprayed 
with both vanillin and ninhydrin spray reagents to help prove their identity.  
 
Compound 3: 
The column was washed with CHCl3/MeOH (6:4 – 100%), concentrations were increase by 1% 
MeOH for every 500 ml used. These Erlenmeyer flask fractions were covered with a cotton wool 
plug and placed in an open space at room temperature and allowed to stand until complete 
evaporation had occurred.  Some fractions (view section 3.3.1.3 Isolation and purification of 
compounds 2 and 33.3.1.3 Isolation and purification of compounds 2 and 3; Figure3.4, page 
40) produced similar crystals and so the fraction with the most crystals was selected for further 
analysis. These crystals were dissolved in 1 ml H2O and analysed on TLC in the same solvent 
system used for compound 2, before being sprayed with vanillin. Unfortunately, the oil in these 
samples could not be separated from the crystals and this led to the compound streaking on the 
TLC plate. The sample was evaluated against table sugar as a control, as it was suspected to be 
sucrose. To prove if this compound was sucrose, NMR analyses were performed on these 
samples. 
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3.3.1.4 Isolation and purification of compound 4 
Approximately 1 g of EtOH crude extract (SCE-187-46208) was dissolved in 15 ml MeOH. The 
solution was divided into two (7.5 ml each) and applied onto two separate aluminium TLC plates. 
Hex/EtOAc/Et2N (hexane/ethyl acetate/diethylamine) (6:4:1) was the solvent system used to 
develop the plates. UV active bands were circled and removed from the plate. Similar bands on the 
TLC plate were combined and cut into small pieces and placed in a 10 ml beaker. The compound 
was extracted with MeOH. The solutions was filtered and concentrated by solvent pervaporation 
under a cool stream of air. The compound was then dissolved in 1 ml MeOH and analysed using 
TLC to confirm that it was a pure compound for further analysis by NMR. The compound was 
dissolved in deuteratedCHCl3 (CDCl3), filtered and analysed. 
 
3.3.1.5 Isolation and purification of compound 5 
About 1 g of MeOH crude extract (SCE-187-46222) was dissolved in 10 ml MeOH. About 5 ml of 
the mixture was applied on each of the two prep-TLC glass plates and eluted with Hex/EtOAc/Et2N 
(6:4:1). All UV active bands were circled and similar bands were combined in one beaker. The 
compounds were extracted from the silica using MeOH, filtered and concentrated. As such, the 
volume of MeOH used to dissolve the compounds varied from beaker to beaker, as the amount of 
silica in the beakers was not identical. The dry compounds were then dissolved in 1 ml MeOH and 
analysed by TLC using the same solvent system as above. Preparative TLC was repeated on 
individual compounds to further purify them for NMR analysis. Two compounds were successfully 
purified, one of these being compound 1, while a second compound was also identified and 
confirmed with NMR experiments. This compound was then labelled as SCE-187-46311-B. 
 
3.3.2 HPLC analysis 
The HPLC technique was used to chemically profile the plant extracts, while mass spectrometry 
was used to verify the molecular weight of some of the isolated compounds including mesembrine, 
∆4mesembrenone and obtusalin. Analytical (chromatographic) methods were developed by Mr. 
Nial Harding, who, together with Dr Paul Steenkamp, generated the data for subsequent   analysis. 
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About 25 mg of the ethanol extract (sample number: SCE-187-46208 ECD-MP-0054) was weighed 
into a 5 ml vial. To this 5ml of methanol was added. The vial was then placed in an ultrasonic bath 
(Integral systems, Main 220 V. RSA) until the extract was dissolved. The sample was filtered 
through a 0.2 µm filter membrane GMP using a 2 ml syringe (Norm-jectLuer Lock) and collected 
into an HPLC vial.4 About 2.0 g of pre-dried plant material provided by ECD (sample numbers: 
TTSI-MP-0013 and TTSI-MP-0015) was weighed out and ground into powder. Each was extracted 
into 5 ml of ethanol and left to stand for four hours, before being placed in the ultrasonic bath (no 
heat applied) for a further one hour. The extract was then filtered and transferred into an HPLC vial 
as described above. Two capsules of S. tortuosum (kana) were emptied into a 5 ml volumetric 
flask; the powder was extracted into 5 ml of ethanol as described above. The sample was then 
filtered and transferred into an HPLC vial as described for the first sample. The tincture was not 
treated before use.  
 
3.3.2.1 HPLC-UV-MS analysis 
Extracts and compounds were analysed with a Waters Alliance 2695 HPLC linked to a Waters 
XBridge C18 3.5 µm, 2.1x150 ml dimension column. Separation required a pH of approximately 10, 
thus 10 mM ammonium bicarbonate buffer (pH 10) was used. The sample injection volume was 5 
µl. UV detection was done on a Waters 996 PDA scanning from 210-400 nm. Running conditions 
are summarised in Table 3.1. 
 
 
 
 
 
 
 
 
                                                          
4
 Note: The method was followed for all extracts analysed. 
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Table 3.1: HPLC gradient timetable/method 
 
 
 
 
 
 
 
 
 
Mobile phase used 
Solvent B – 20.0% Methanol 
Solvent C – 80.0% 10 mM (NH3)2HCO3.H2O 
 
3.4 NMR sample preparation 
Compounds were purified in the laboratory as described in Section 3.3. The compounds were 
concentrated by solvent pervaporation under a stream of cold air. Deuterated solvents (MeOH, 
CHCl3 and DMSO) were used to dissolve the compounds according to their solubility. Once 
dissolved, the compounds were filtered through compressed cotton wool before being added into 
the NMR tubes. 1H, 13C, and other two dimension (2D) experiments required were conducted using 
the Varian 600 MHz NMR instrument. Time duration of these experiments and the quality of the 
results depended on the sample concentration. 
 
Time (min) Flow rate (ml/min) % B % C %D 
0.00 0.3 20.0 80.0 0.0 
10.00 0.3 20.0 80.0 0.0 
12.00 0.3 25.0 75.0 0.0 
40.00 0.3 30.0 70.0 0.0 
48.00 0.3 45.0 55.0 0.0 
80.00 0.3 70.0 30.0 0.0 
100.00 0.3 0.0 0.0 10.00 
107.00 0.3 0.0 0.0 10.00 
110.00 0.3 20.0 80.0 0.0 
120.00 0.3 20.0 80.0 0.0 
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3.5 Biological Assay: 
3.5.1. Bioassay approach to screen for biological activity of various compounds isolated 
from S. tortuosum. 
3.5.1.1 Malaria Rapid Diagnostic Tests (RDTs) 
The malaria rapid diagnostic tests (RDTs) include immunochromatographic tests (ICTs) that target 
antigens on one or more Plasmodium species (Maltha et al., 2010).  As such, these RDTs were 
chosen as one of the bioassay options, but not specifically directed towards finding anti-malarial 
activity of any of the compounds isolated from S. tortuosum. 5  Positive ICT results would be 
indicated by two to three test lines that turn cherry-red to purple with one of these lines being a 
control line (to indicate if the test was performed correctly). The original two band ICT generates a 
test line that targets P. falciparum by detecting either histidine-rich protein 2 (HPR-2) or P. 
falciparum-specific parasite lactate dehydrogenase (Pf-pLDH) (Piper, 2011; Maltha et al., 2010). 
 
The more recently developed three band ICTs include a second target that is common to the four 
Plasmodium species, including aldolase or pan-specific parasite lactate dehydrogenase (pan-
pLDH). A concern with the three-band ICTs is that this test detects a P. falciparum-specific antigen 
and a pan-Plasmodium antigen that cannot be used to distinguish between a P. falciparum 
infection and a mixed infection with P. vivax, when both test lines are simultaneously observed. 
Discrimination between the two species is important; since both P. falciparum and P. vivax require 
different treatment scenarios (Maltha et al., 2010). 
 
3.5.2. Plasmodium lactate dehydrogenase (pLDH) screening 
The enzyme lactate dehydrogenase (LDH) is found in all cells (prokaryotes and eukaryotes), being 
a catalyst in the formation of pyruvate from lactate (Vander Jagt et al., 1990). It was then reported 
that parasite lactate dehydrogenase (pLDH) activity is distinguishable from host LDH activity on the 
basis of the unique epitopes found in the pLDH protein, as well as on the enzymatic characteristics 
i.e. by its capability to use the 3-acetyle pyridine adenine dinucleotide (APAD) analog of 
nicotinamide adenine dinucleotide. Such an observation has led to the development of an 
enzymatic method for the evaluation of anti-malarial compounds (Makler et al., 1993; Makler et al., 
                                                          
5
 Nevertheless, a detailed account on the pathogenesis and distribution of malaria infections is included in Appendix 5. 
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1998). By way of contrast, usage of the pLDH assay has been extended to the examination stage, 
to determine the presence of pLDH antigen in lysed whole blood (Cooke et al., 1999). In the 
process, LDH reduces nicotinamide adenine dinucleotide (NAD) co-enzyme to NADH. The NAD 
analogue APAD is reduced to APDH, which reduces the chromogenic substrate Nitro Blue 
Tetrazolium (NBT) using the enzyme diaphorase and changing the substrate from a yellow colour 
to a purple formazan product (see Figure 3.5). The host erythrocyte lactate dehydrogenase activity 
can easily be distinguished from the pLDH, as it is incapable of using APAD as a co-factor. To 
quantitate the formazan formation, a spectrophotometer is used to read light absorbance of each 
well at 620 nm. Formazan levels are used to measure parasite survival in the presence of the test 
compound. Formazan levels, thus, depend on pLDH activity that also acts as an indicator of 
parasite concentration in the culture (Piper et al., 1999; B.P.R.C., 2010). 
 
Schematic representation: 
 
 APAD + Lactate  
     
 
APADH + Pyruvate  
   NBT 
 
 
APAD   +   NBF 
 
Figure 3.5: Schematic representation of the principle behind the pLDH assay. 
Diaphorase 
pLDH 
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3.5.3. Preparation of test samples and standards 
The following protocol is a standard method which was followed for all experiments undertaken for 
anti-malarial screening. A stock solution of 20 mg/ml in 100% MeOH/DMSO/H2O was prepared. 
This was followed by 1:10 dilution of the stock solution in complete medium (CM), to obtain the 
desired starting concentration (200 µg/ml, 20 µg/ml or 2 µg/ml). The final concentration and solvent 
percentages were, therefore, 100 µg/ml (0.5%), 10 µg/ml (0.05%) and 1 µg/ml (0.005%). Wells 
treated with chloroquine was used as the reference standard. 
 
3.5.4. Preparation of micro-titre plates (96 wells) 
The assays were performed when the parasites were in their trophozoite stages. Thus, blood with 
a 2% haemotocrit and 2% parasitaemia (3D7 falciparum strain) was prepared. All 96 well 
experimental plates were labelled, divided and prepared as indicated in Figure 3.6: In column 1, 
100 µl of 2% haematocrit blood and 100 µl of complete medium (CM), (prepared with RPMI 1640 
Media 500 ml containing L-Glutamine and 25 mM HEPES, 2 g Glucose, 0.044 g Hypoxanthine, 2.5 
g Albumax II and 0.6 ml Gentamicin, (supplied by Whitehead Scientific) was added. In column 2, 
100 µl of 2% parasitaemic blood and 100 µl of CM were added. Column 3 represented test 
samples, and to each of three wells was added 150 µl of test sample in triplicate. A volume of 100 
µl CM was added in column 4 right through to column 12. Three-fold serial dilutions of test samples 
were prepared using CM from column 3 – 12 (Serial dilutions: 50 µl CM was added to 100 µl in 
Compound 5 (column 4), mixed, then 50 µl was taken from column 4 into column 5. The process 
was repeated until column 12 was reached, with the remaining 50 µl in tubes being discarded. 
About 100 µl of 2% parasitaemic blood was added to columns 3– 12, bringing the final volume in 
each well up to 200 µl. The plates were then covered with a lid and placed in a  chamber, where 
they were  gassed (Fresh line Mixture Inert gas heavier than air CO2, 5% O2 balance N2, Air 
products, K360C) for approximately 1 minute, before  being  placed in a 37oC incubator for 48 
hours. 
 
 
 
 
 
  
 
 
 
Figure 3.6: Photograph of one of the single concentration 
blood cells. Negative Control –blank, CQ 
numbers i.e. 69A are number of samples.
 
 
3.5.5. Preparation of reagents for plate development
Malstat:  400 µl Triton X-100 
4 g L–lactate 
1.32 g Tris buffer 
Add 200 ml mH2O. Stir until dissolved.
Add 22 mg of APAD and pH titrated down 
NBT/PES: 160 mg Nitro blue tetrazolium salt
8 mg phenazineethosulphate
Add 100 ml mH2O. Cover the bottle with foil.
Store at 4˚C  
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3.5.6. Developing plates (Non-sterile) 
For each experiment, fresh microtitre plates were prepared and to each well was added 100 µl of 
malstat. About 20 µl of cell suspension was added to the wells, which was followed by the addition 
of 25 µl of nitro blue tetrazolium (NBT, Merck, RSA) chloride. As the reagents used in this step 
were light sensitive, plates were kept in a dark area and covered with foil for 2-3 minute incubation 
periods. The absorbance of the individual wells in each plate was then measured at 620 nm 
(TecAN – Manufacturer, Infinite F 500). All of these experiments were done in triplicate. 
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Chapter 4 
Results and Discussion 
 
Amongst other compounds, S. tortuosum is known to contain alkaloids. Alkaloids are complex 
molecular structures containing heterocyclic-bound nitrogen atoms, with more or less expressed 
basic character associated with pronounced physiological action of being found in both plants and 
animals. These highly bioactive plant compounds were commonly used in all major human cultures 
since ancient times (Zenk and Juenger, 2007).  
 
Sceletium has been known as a traditional sedative of the Khoi-San people of the Cape Province 
of South Africa, being a plant that is widely used for its mood elevating properties, as well as its 
ability to reduce anxiety and stress (Gericke & Viljoen, 2008). Currently, Sceletium is marketed 
through health shops and on the internet as dried plant powder and in capsules, tinctures and tea 
bags. This plant is alleged to be useful in the treatment of psychological disorders and studies were 
required to identify compounds present within the extract. Since there were no available analytical 
methods in the literature and no commercially available standards of relevant alkaloids for use in 
the analysis and quality control of Sceletium products and dosage forms, Patnala and Kanfer 
(2010) took it upon themselves to isolate and characterize appropriate analytical markers for use in 
assays and as well as markers for fingerprinting by HPLC. The main objectives of their study were 
the development of an efficient HPLC method for the separation and quantitative analysis of the 
relevant alkaloid components in Sceletium,  as well as to reduce the RT of epimesembranol, in 
particular, from >30 min.  
 
In this particular study, the identity of the peaks in the standard chromatogram was confirmed by 
the respective spectral data generated from several analytical techniques, including 1H, 13C and 2D 
NMR and mass spectroscopy. The accuracy of the methods used was found to be between 96.9% 
- 100% for all five compounds. The recovery of all five identified alkaloids was seen to be in the 
range of 95% - 100%. Almost 80% of known natural substances are non-volatile and thermolabile, 
making HPLC with UV detection the most commonly used analytical technique for natural products 
(Abian, 1999). Photo diode array (PDA) detectors enhance the versatility of analysis, by allowing 
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multi-wavelength detection of compounds based on their distinct chromophore active regions, thus 
making PDA a very useful analytical technique, particularly for multi-component sample analysis 
and/or compound identification (Patnala & Kanfer, 2010). In the present study, nuclear magnetic 
resonance spectroscopy of isolated compounds was performed using a Varian-NMR (600 MHz) 
instrument. The spectra were recorded at 25oC, with chemical shifts of the different molecular 
components being recorded along the ppm-axis coupled to hertz. Deuterated solvents, such as 
CDCl3, D2O and DMSO were used, depending on the polarity of the compound and the relaxation 
times (Ti) required, generating spectral data of the components of each molecule of interest. 
4. Analysis of Compound 1 
The history of the phytochemical analysis of the genus Sceletium is believed to go back to 1898 
when Meiring isolated a crude alkaloid mixture from Sceletium tortuosum. Meiring’s research was 
reportedly followed by the work done by Zwicky (quoted in: Smith et al., 1998) who isolated a 
number of alkaloids including mesembrine and mesembrenone. Later in 1967, Popelak and 
Lettenbauer (1968) suggested that the “mesembrine” Zwicky isolated was probably not a pure 
compound. Therefore, they corrected the molecular formula for mesembrine from C16H19NO4N to 
C17H23NO3 which was later confirmed by the well-known German pharmaceutical company C.F. 
Boehringer and Soehne in the early 1960’s and also by S.B. Penick in New York (Gericke & 
Viljoen, 2008). 
 
While some believe the structural elucidation of mesembrine commenced in 1967 by Zwicky, other 
researchers believe the structural investigation began in 1975 when it was revealed that 
mesembrine contains a ketone, a tertiary amine and two methoxy substituents. It is, however, 
agreed that Popelak and co-workers completed the structural elucidation through a combination of 
degradation and synthetic methods (Denark and Marcin, 1997). The alkaloids of Sceletium species 
are said to be derived from the aromatic amino acids phenylalanine and tyrosine by a complex 
series of reactions that are only partly understood (Jeffs et al., 1977). It is believed that 
mesembrine is the main compound or alkaloid responsible for mood elevating and the stress- and 
anxiety-reduction effects of the plant (Geriken & Viljoen, 2008). Jeffs (et al., 1977) disagrees with 
this and argues that mesembrenone could well be the psychoactive constituent of “kougoed”. He 
based this conclusion on the elevated quantity of mesembrenone observed following fermentation 
 38 
 
of the fresh Sceletium material he was working on.  It was also found that although the intoxicating 
doses can be euphoric, the plant is not hallucinogenic, but is a narcotic-anxiolytic (Smith et al., 
1995). Research shows that pharmacologically, mesembrine acts as a serotonin re-uptake inhibitor 
(Gericke & Viljoen, 2008). 
4.1 Identification of Compound 1 as Mesembrine 
Mesembrine is a sticky, yellow compound and in the current study, compound 1, upon spraying a 
TLC plate with ninhydrin, presented with a pink centre with a yellow outer circle. The structural 
elucidation of the compound was based on 1H and 13C experiments. The 1H and 13C chemical 
shifts for the unknown compound were compared to those found in the literature for mesembrine 
(Gu and You, 2011). Table 4.1 and Table 4.2 shows that the NMR spectral data for compound 1 
agrees with published values for mesembrine (Gu and You, 2011). The proton spectrum shows 
three conspicuous proton signals at H 3.89, 3.87 and 2.30 ppm. These three signals resonate with 
the two methoxy groups in the aromatic ring and one N-methyl group (Appendix 6).  Also present 
are aromatic protons between H 6.92 and 6.83 ppm. The relics of the rest of the peaks resonate 
between H 2.60 and 2.00 ppm. These signals are highly congested and, thus, present with signal 
overlapping, thereby making it impossible to individually analyze each signal. When analyzing the 
carbon 13 spectrum of compound 1, a carbonyl carbon peak is observed downfield resonating at 

13C 211.4. There are six peaks in the aromatic region, resonating between 13C 100.0 and 160.0. 
These peaks signify the presence of a benzene ring. The mass spectrum of compound 1 observed 
below (Figure. 4.1) showed a peak at m/z 290.1757 (ESI+), as was shown for mesembrine by 
Patnala and Kanfer (2009).  
 
Table 4.1: 
1
H NMR spectral data of Compound 1 (CDCl3) in comparison with that found in the literature (Gu & You, 
2011). 
Compound 1 
H (J in Hz)(Isolated) H (J in Hz)(Literature) 
2.09 – 2.22 (m, 5H) 2.08 – 2.25 (m, 5H) 
2.30 (s, 3H) 2.33 (s, 3H) 
2.24 (s, 2H) 2.30 (m, 2H) 
2.58 (brs, 2H) 2.62 (d, J = 3.3, 2H) 
2.93 (brs, 1H) 2.96 – 2.98 (m, 1H) 
3.11 – 3.13 (brt, 1H, J = 7.7) 3.13 – 3.18 (m, 1H) 
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3.89 (s, 3H) 3.89 (s, 3H) 
3.91 (s, 3H) 3.19 (s, 3H) 
6.83 – 6.92 (m, 3H) 6.84 – 6.93 (m, 3H) 
 
Table 4.2: 
13
C  NMR spectral data of compound 1 (CDCl3) in comparison to that found in the literature (Gu & You, 
2011). 

 13C  (Isolated)  13C  (Literature) 
56.0 55.9 
36.2 36.1 
47.5 47.4 
35.3 35.2 
40.6 40.5 
211.4 211.5 
38.8 38.7 
70.4 70.3 
40.1 40.0 
140.2 139.9 
111.7 110.7 
149.0 148.8 
147.5 147.3 
110.0 109.6 
117.9 117.8 
54.8 54.8 
55.9 55.8 
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Figure 4.1: ESI
+
 TOF mass spectrum of isolated mesembrine 
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Figure 4.2: UV absorption spectrumof mesembrine detected in crude SCE-187-46208 
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HPLC is used routinely in phytochemistry to provide efficient separation of metabolites and is a 
valuable quality control in standardization of sample preparation techniques (Marston, 2007). 
Patnala and Kanfer (2010) performed quantitative determination of relevant alkaloids within S. 
tortuosum extracts. They then obtained UV peaks (Appendix 29) of each alkaloid of interest 
present in their plant stock. A UV spectrum of Compound 1 is depicted in Figure 4.3 to show that 
this UV data and the MS data compares to that presented by Patnala and Kanfer (2009) for 
mesembrine. Taken together, these data confirm that compound 1 is mesembrine with the 
following structure: 
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Figure 4.3: Structure of Compound 1 (Mesembrine) 
 
4.1.1. Characterization of Compound 2  
This compound was isolated by column chromatography. It then crystallised as different shapes 
and colours ranging from white to light brown in separate fractions. Analysis of this compound by 
column chromatography followed by TLC and staining with ninhydrin and vanillin indicated a bright 
pink streak when sprayed with ninhydrin and with a dark black streak when sprayed with vanillin. 
Structural elucidation of this compound was based on 1H and 13C NMR experiments. 
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Table 4.3: 
1
H NMR spectral data of compound 2(dissolved in deuterated DMSO) in comparison with that described 
in the literature for pinitol (Blanco, 2008). 
Compound 2 
Proton number: H (J in Hz)(Isolated) H (J in Hz)(Literature) 
1 3.61 (s) 3.62 (m) 
2 3.48 (m) 3.50 (m) 
3 2.98 (t, J = 9.4) 3.00 (t) 
4 3.33 (brs) 3.32 (dd) 
5 3.42 (brs) 3.41 (m) 
6 3.61 (brs) 3.62 (m) 
OCH3 3.42 (s) 3.44 (s) 
OH – 1 4.31 (d, J = 5.3)  4.34 
OH – 2 4.44 (d, J = 6.3) 4.46 (d) 
OH – 4 4.48 (d, J = 4.4) 4.51 
OH – 5 4.60 (brs) 4.63 (brs) 
OH – 6 4.69 (brs) 4.72 (brs) 
 
 
Table 4.4: 
13
C NMR spectral data of compound 2 (dissolved in deuterated DMSO) in comparison to that in literature 
(Pyridine deutorated) (Misra & Siddiqi, 2004). 
Compound 2 
Carbon number:  13C (Isolated)  13C (Literature) 
1 83.8 85.9 
2 71.0 73.1 
3 72.4 74.2 
4 70.1 72.3 
5 73.6 74.7 
6 72.0 73.8 
OCH3 59.6 60.8 
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Figure 4.4: Structure of Compound 2 (Pinitol) 
 
Pinitol or O-methyl inositol (1-methoxy-2,3,4,5,6-penta-hydroxyl cyclohexane) is a natural product 
of a cyclitol group occurring mainly in its positive (+) from. It has been shown to be a feeding 
stimulant for larvae of the yellow butterfly Euremahecabemandarina and also inhibits larval growth 
of Heliothiszea on soybeans (Ley and Sternfeld, 1989; Misra and Siddiqi, 2004). Pinitol also exerts 
some sort of insulin-like effect due its involvement downstream of the cellular signal transduction 
mediate by the insulin receptor (Kim et al., 2005). Pinitol has been isolated from the leaves of 
Bougainvillea spectabilis and was found to have anti-diabetic and hypoglycaemia-inducing 
properties (Misra & Siddiqi, 2004). Misra and Siddiqi (2004) agree that spectra supporting data of 
(+)-pinitol are not readily available, particularly data involving 13C NMR. For that reason, a carbon 
spectrum of (+)-pinitol using pyridine as deuterated solvent of choice was utilized as reference for 
compound 2. 
The NMR proton spectrum indicated a methyl proton peak resonating at H 3.42. The peak is 
shifted more downfield than would normally appear and this is due to the presence of an oxygen 
molecule attached to the methyl group. This peak is situated in the region between H 2.90 and 
3.60 where all explicit protons being H-1 to H-6 are saturated. Furthermore, all five oxygenated 
hydrogens are clustered between H4.30 and 4.00, with protons OH-5, OH-4 and OH-2 presenting 
as doublets (Appendix 11). In the carbon 13 spectrum, the methyl carbon resonates at 13C 59.6. 
The rest of the carbons (C-2 to C-6) resonate between 13C70.00 and 72.60 ppm. These peaks are 
clustered in that region, indicating the presence of a ring structure. C-1 resonates at 13C83.80, 
more downfield than other carbon peaks and this is due to the oxygen molecule attached to it. 
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4.1.2. Characterization of Compound 3 
Sucrose was isolated from one of the fractions after washing the column using highly polar 
solvents (Figure. 3.4). The crystallized compound consisted of clear square crystals. Brown oil was 
mixed with the crystals and could not be completely removed by washing. Although the compound 
could not be identified by TLC, it stained black after spraying with vanillin. To confirm the identity of 
this compound, the structure was elucidated using NMR in comparison to commercially available 
sucrose (table sugar). 1H and 13C spectra of both samples were obtained and the resulting 
chemical shifts were compared to one another and to those found in the literature (SDBS –
riodb01.ibase.aist.go.jp; Popov et al., 2006).  See Table 4.5 and Table 4.6 in this regard.  
 
Table4.5: 
1
H NMR spectral data of Compound 3 (D2O) and commercially available (D2O) sucrose in comparison to 
that found in literature (D2O) (SDBS – www.aist.go.jp). 
Compound 3 
Proton 
numbers: 
H(J in Hz) H(J in Hz ) H(J in Hz) 
1 5.30 (d, 1H, J = 3.5) 5.27 (d, 1H, J = 3.5) 5.41 
2 3.44 (dd, 1H, J = 3.0, 10) 3.42 (dd, 1H, J = 3.5, 10.1) 3.56 
3 3.64 (t, 1H, J = 9.7) 3.61 (t, 1H, J = 9.4) 3.76 
4 3.35 (t, 1H, J = 9.4) 3.32 (t, 1H, J = 9.4) 3.47 
5 3.72 (m, 1H) 3.70 (m, 1H) 3.86 
6 3.70 (brs, 2H) 3.67 (brs, 2H) 3.81 
1’ 3.56 (brs, 2H) 3.53 (s, 2H) 3.67 
2’ 
   
3’ 4.06 (d, 1H, J = 8.8) 4.07 (d,1H, J = 8.8) 4.21 
4’ 3.93 (t, 1H, J = 8.9) 3.90 (t, 1H, J = 8.5) 4.05 
5’ 3.77 (m, 1H) 3.75 (m, 1H) 3.89 
6’ 3.70 (brs, 2H) 3.68 (brs, 2H) 3.83 
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Table 4.6: 
13
C  NMR spectral data of Compound 3 (D2O) and commercially  available (D2O) sucrose to that found in 
literature (D2O) (Popov et al., 2006). 
Compound 3 
Carbon numbers:  13C  (Isolated)  13C (Table sugar) 13C  (Literature) 
1 92.2 92.1 92.3 
2 71.0 71.0 71.1 
3 72.5 72.5 72.5 
4 69.2 69.1 69.3 
5 72.4 72.3 72.3 
6 60.1 60.0 60.2 
1’ 61.4 61.3 61.4 
2’ 103.7 103.6 103.5 
3’ 76.5 76.3 76.6 
4’ 74.0 73.9 74.1 
5’ 81.3 81.3 81.3 
6’ 62.4 62.3 62.4 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5: Structure of Compound 3 
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Sucrose (β-D-fructofuranosyl-α-D-glucopyranoside) is one of the most common sugars, occurring 
widely in plants, fruits and honey. Both of the sucrose rings behave together as a single rigid entity, 
bound by intramolecular hydrogen bonds and reorienting isotropically in an aqueous solution. 
Thus, a dissociation of one hydroxyl-group in some way affects the entire molecule (Popov et al., 
2006).  
 
In the proton spectrum, proton peaks resonated between H 3.2 and 5.30 ppm. This is due to the 
absence of methylated protons in this compound and to the oxygen molecules binding to eight of 
the fourteen protons resulting in the protons being shifted downfield. H- 6’ and H-6 resonated at  
3.70 ppm.  These two signals overlap because H-6 presented with a broader peak masking the 
resonance of H-6’.  H-5’ presented as a multiplet due to the effects of the multiple protons in the 
field and the oxygen molecules present. H-1 resonated at  5.30 ppm and the reason for this 
proton to be moved further downfield compared to the rest of the protons is the fact that C-1 is 
directly bound to the two oxygen molecules and to C-2 that has an OH substituent. Twelve peaks 
were observed between  60.0 and 104.0 ppm of the 13C spectrum. Typically of the sucrose carbon 
spectrum, the CH2 carbons (C-6, C-1’, C-6’) resonate between 60.0 ppm and 63.0 ppm. These 
carbons are also bound to an OH group. A group of seven CH molecules resonates further 
downfield between 69.0 and 80.0 ppm region. There is one anomeric carbon signal resonating at 
92.2 ppm which is typical of an α-orientation hydroxyl group attached to C-1 position. Sucrose is 
one of the most common disaccharides with a quaternary acetal carbon signal resonating at 103.7 
ppm.  The NMR data obtained for this compound were in close agreement with that published in 
literature of the sucrose molecule (Popov et al., 2006) 
 
4.1.3. Characterization of Compound 4  
As noted by Patnala and Kanfer (2009), some publications suggest that unspecified 
mesembrenone and other alkaloidal changes resulted from crushing and bruising of the plant 
material. These authors subsequently carried out a further study which revealed that the 
fermentation process undeniably transformed mesembrine to ∆4mesembrenone. They stated that 
this process required the presence of an aqueous environment together with the presence of light 
to facilitate such a transformation. In this particular study, this was not the case, as the plant 
material was only crushed and bruised before extraction. Nevertheless, change of, or gradual 
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reduction of mesembrine was noticed in various extracts, together with those that resulted from 
fermentation of the plant material itself. From this plant, ∆4mesembrenone was isolated using prep-
TLC, appearing as a white solid film that adhered to glassware. Although this compound was found 
to be UV active, there was no colour change after spraying with ninhydrin. The structural 
elucidation of the compound was based on 1H and 13C experiments. The 1H and 13C chemical 
shifts were compared to those of Bastida et al., (1989) and Jeffs et al., (1974).The 3a-aryl-cis-
octahydronindone skeleton is a constituent of the major subgroup of mesembrine alkaloids which 
includes ∆4 and ∆7mesembrine-type series, based on the two double bonds at either position 4 - 5 
or 7 - 7a, respectively (Patnala and Kanfer, 2008). Like mesembrine, this compound has been 
isolated and published in the literature and, therefore, structural elucidation depended solely on 
comparison of the 1H and 13C NMR experimental data, with that found in the literature. 
 
Table 4.7: 
1
H NMR spectral data of compound 4 (CDCl3) in comparison with that found in literature (CDCl3) (Bastida 
et al., 1989). 
Compound 4 
Proton number H, ( J in HZ) (Isolated) H, (J in Hz) (Literature) 
2 3.32 (1-H, brt; J = 5.4) 3.34 (1-H, m) 
2 2.51 (1-H) 2.50 (H-7) 
3 2.44 (1-H, brd; J = 6.5) 2.42 (1-H, dd; J = 8.4, 2.4) 
3 2.20 (1H-, brdd; J = 8.8, 4.7) 2.21 (1-H, ddd, J = 12.6, 8.4, 4.2) 
4 6.73 (1-H, brd; J = 8.8) 6.74 (1-H, d; J = 10.1, 2.0) 
5 6.11 (1-H, brd; J = 10.6) 6.11 (1-H, dd; J = 10.1, 0.8) 
7 2.57 (1-H, brs) 2.55 (1-H, brd) 
7 2.51 (1-H, brs) 2.50 (1-H, dd; J = 8.4, 4.8) 
7a 2.67 (1-H, m) 2.65 (1-H, m) 
NCH3 2.32 (3-H, s) 2.32 (3-H, s) 
2’ 6.88 (1-H, s) 6.88 (1-H, s) 
5’ 7.03 (1-H, d; J = 8.2) 6.89 (1-H, d; J = 8.0) 
6’ 6.84 (1-H, d;J = 8.0) 6.82 (1-H, d; J = 8) 
O CH3 3.88 (3-H, s) 3.89 (3-H, s) 
O CH3 3.89 (3-H, s) 3.90 (3-H, s) 
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Table 4.8: 
13
C  NMR spectral data of compound 4 (CDCl3) in comparison with that found in literature (CDCl3) (Jeffs et 
al., 1974). 
Compound 4 
Carbon number 13C (Isolated) 13C (Literature) 
2 56.1 56.2 
3 37.8 38.3 
3a 50.9 50.9 
4 153.7 153.3 
5 126.5 126.2 
6 197.4 196.9 
7 38.7 38.6 
7a 73.8 73.8 
NCH3 40.1 40.1 
1’ 135.8 135.2 
2’ 111.2 110.9 
3’ 149.1 148.6 
4’ 148.2 147.7 
5’ 110.2 110.0 
6’ 118.1 118.8 
O CH3 55.8 55.8 
O CH3 55.9 55.9 
 
 
Sceletium’s ∆4 mesembrenone and ∆7mesembrenone are some of the compounds that have been 
isolated from S. tortuosum as reported in the literature. These compounds are similar in structure, 
with the only difference being in the stereochemistry of the double bond found in the six membered 
ring. In ∆4mesembrenone, the double bond is found between C-4 and C-5, whereas the double 
bond in ∆7mesembrenone is found between C-7 and C-7a. Although the difference between the 
two structures is negligible, in essence it is possible to compare the NMR parameters of one with 
the other. From an NMR perspective, the difference in stereochemistry between the two 
compounds has a huge impact on the proton and carbon resonance spectra. Carbon 13 NMR and 
proton NMR spectral data are in agreement with that found in the literature (Bastida et al., 1989 
 50 
 
and Jeffs et al., 1974). There are proton signals found in the 1H spectra of mesembrenone that are 
unique to this compound. A singlet at H 2.32 represents the N-methyl group. The two signals at H 
3.89 and H 3.90 represent the methoxy groups. There is broad doublet at H 6.73 with a coupling 
constant of 8.8 Hz. The two olefinic protons H-4 and H-5 are represented by a broad doublet with a 
coupling constant of 10.6 Hz. The two unique doublets representing the aromatic protons 
resonated at H 6.84 and H 7.03. In the analysis of the 13C spectra, the NMe group resonated at 
C
13
 40.1. The C-3a quaternary carbon resonated at H 50.9. The two methoxy groups are 
represented by peaks at H 55.8 and H 55.9. Due to the presence of the oxygen, the carbonyl 
group shifts more downfield away from the rest of the carbons. This peak is usually found around  
200. C-6 carbonyl group of this compound resonated at H 197.4.  
 
Standards of the S. tortuosum compounds similar to those described by Patnala and Kanfer (2008) 
were isolated from the plant material, while some standards were purchased for comparative 
purposes. An HPLC profile of the four standards (∆7mesembenone, mesembranol, mesembrenone, 
∆
4mesembrine and epimesembranol) was compiled (see below – Appendix 29) as well as an LC-
MS chromatogram of the ∆7 mesembenone peak (Appendix 21). These data (Patnala and Kanfer, 
2008) were used to compare with the LC-MS of the laboratory-isolated ∆4 mesembrenone (isolated 
in this study – Figure 4.8, 288 m/z). The information seemed to be in direct agreement with the 
major peak resonating at 288 m/z on the chromatogram. View Figures. 4.6 and 4.7 for the results 
obtained by Patnala and Kanfer (2009). Although Patnala and Kanfer (2009) reported on 
∆
7mesembrenone, the data are still applicable and can be used for comparison as these two 
compounds are of the same mass.
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Figure 4.6: Mass spec of Mesembrenone isolated from crude SCE-187-46208. Showing a peak at 299.35 m/z that is a representative of mesembrenone. In 
this case, ∆
4 
mesembrenone and ∆
7
 mesembrenone share the same molecular weight of which the stereo chemistry of the structure is used to determine 
which the correct compound.  
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Figure 4.7: LC-MS chromatogram of crushed plant material on day 10. MS Ion spectra of ∆7 mesembrenone m/z 288.2 (top), mesembrine m/z 290.2 
(middle) and TIC (bottom) (Patnala and Kanfer, 2009).  An HPLC representative of S. tortuosum purchased standards used in the experiments carried out 
by Patnala and Kanfer, 2009 (bottom spectrometer) as well as MS ion peaks of two compounds as forth mentioned.  
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Figure 4.8: Structure of Compound 4 
 
4.1.4.  Characterization of compound 5 
According to the literature, no triterpenoid has been previously isolated from phytochemical 
investigations on S. tortuosum. Triterpenoids are commonly found in most plants and are produced 
by arrangements of squalen epoxide in a chair-chair-chair-boat arrangement subsequently followed 
by condensation (Patočka, 2003). These compounds are isopentenoids composed of thirty carbon 
atoms and may possess acyclic, mono, di-, tri-, tetra- or pentacyclic carbon skeletons. Pentacyclic 
triterpenoids are dominant constituents of this class and have been widely investigated (Mahato 
and Kundu, 1994).  
 
Obtusalin7 is a pentacyclic triterpene belonging to the lupane class of compounds (Zheng et al., 
2010) that was first isolated by Siddiqui and colleagues in 1989 from the leaves of Plumeria 
obtusa. Different parts of this plant have been used as a laxative, menstrual flow enhancer and as 
a fever-reducing medicine (Siddiqui et al., 1989). Obtusalin is an addition to the few naturally 
occurring pentacyclic triterpenoids possessing a C-27-hydroxyl group in conjunction with a double 
bond at C-12 in the lupine chain of triterpenoids (Begum et al., 1994 and Siddiqui et al., 1989). 
Pentacyclic triterpenes are reported to possess a wide spectrum of biological activities, where 
some may be used as medicines (Patočka, 2003). The genus Plumeria has a medicinal value in 
indigenous systems, particularly where some of its species have shown antibiotic effects. While 
different parts of P. obtusa have presented with certain biological activity (Siddiqui et al., 1989), 
obtusalin was reported to have no intrinsic biological properties (Sharma et al., 2011). P. obtusa 
                                                          
7
 This compound is novel to S. tortuosum and to the family as a whole. 
 54 
 
has no physical, chemical or medicinal properties or attributes in common with S. tortuosum, which 
is what makes this finding so interesting and unique.  
Table 4.9: 1H NMR spectral data of compound 5 (CDCl3) in comparison to that found in literature (CDCl3) (Siddiqui et 
al., 1989) 
Compound 5 
Proton 
Number 
H ( J in HZ)(isolated) 13H(Jin HZ) (Literature) 
3 3.16 (brd, J  = 12.69) 3.21 (dd, J = 10.8; 4.9) 
5 0.68 (brt, J -= 12.1) 0.72 (dd, J = 11.6; 1.5) 
9 1.54 (m) 1.54 (dd, J = 10.0, 3.4) 
11 1.85 (brdd, J = 8.8, 6.4) 1.84 (ddd, J = 13.2, 3.6, 
3.4) 11 1.63 (m) 1.61 (ddd, J = 13.2, 10.0, 
12 5.07 (brs) 5.13 (t, 3.6) 
23 0.94 (s) 1.01 (s) 
24 0.93 (s) 0.98 (s) 
25 0.72 (s) 0.78 (s) 
26 0.88 (s) 0.94 (s) 
27a 3.46 (brd, J = 11.2) 3.52 (d, J = 10.9) 
27b 3.14 (brd, 11.1) 3.18 (d,10.9) 
28 1.03 (s) 1.10 (s) 
29/30 0.87 (brd, J = 5.2) 0.93 (d, J = 5.8) 
30/29 0.75 (brd, J = 7.0) 0.80 (d, J = 5.9) 
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Table 4.10: 
13
C  NMR spectral data of compound 5 (CDCl3) in comparison to that found in literature (CDCl3) (Siddiqui 
et al., 1989 and Begum et al., 1994) 
Compound 5 
Carbon Number 13C (Isolated) 13C (Literature) 
1 38.8 38.8  
2 27.2 27.3 
3 79.0 79.1 
4 38.0 38.0 
5 55.1 55.2 
6 18.3 18.4 
7 32.8 32.9 
8 40.0 40.1 
9 47.6 47.7 
10 36.9 36.9 
11 23.4 23..4 
12 125.0 125.1 
13 138.7 138.8 
14 42.0 42.1 
15 23.4 23.4 
16 26.0 26.0 
17 38.8 38.8 
18 54.0 54.0 
19 39.4 39.5 
20 39.3 39.4 
21 30.6 30.7 
22 35.2 35.2 
23 28.1 28.2 
24 16.8 16.8 
25 15.6 15.6 
26 15.7 15.7 
27 69.9 69.9 
28 23.3 23.3 
29 21.3 21.3 
30 17.3 17.3 
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1H NMR, 13C NMR and MS spectral data of compound 5 are in agreement with those reported in 
the literature for obtusalin (Siddiqui et al., 1989 and Begum et al., 1994). Olefenic protons were 
observed in the proton NMR spectrum (Table 4.9) and resonated at H 5.07,while two secondary 
methyl groups resonated at H 0.87 (J= 5.2Hz) and H 0.75 (J= 7.0Hz), five three-proton singlets 
indicating tertiary methyls that resonated at  0.94, 0.93, 0.72, 0.88 and 1.03.The 13C NMR 
spectrum (Table 4.10) showed the presence of 30 carbon signals: olefinic carbons at C13 125.0 
and C13 138.7; oxygenated carbons at  79.0 and 69.9 and seven methyls at C13 15.6, 15.7, 16.8, 
17.3, 21.3, 23.3 and 28.1.  Accordingly, the structure of compound 5 was assigned as obstusalin. 
The HRTOFMS (ESI+) spectrum (Figure 4.10) of compound 5 showed a pseudo-molecular ion 
signal [M]+at m/z441 which corresponds to the molecular formula C30H50O2. There are significant 
fragments (Figure 4.11) at m/z 191.1800 [234 – isopropyl group]+. This peak strongly indicates that 
the compound is of a lup-12-ene type. Furthermore, the base peak at m/z 441.3689 [234 –
 CH2OH)+] represents the location of the second hydroxyl group at C – 27 as one is present at C -
 3.  
 
 
 
 
 
 
 
 
 
 
Figure 4.9: Structure of Compound 5 
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Figure 4.10: HRTOFMS (ESI+) chromatogram of compound 5 
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Figure 4.11: HRTOFMS (ESI
+
) fragmentation for compound 5. Showing peak fragmentation correlating to those of C30H50O2 with significant fragments which 
strongly suggests that the compound is of a lup-12-ene type.
[M - C16H28O2 + (+OH) ]
 
[M-CH14H24O2 + (+2H)] 
[M – C13H26O2 + (+ 1H)] 
[M – C16H30O2 + (-2H)] 
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4.2 HPLC chemical profiling of crude extracts 
 
Crude extracts of identical plant material were prepared with two different solvents and chemically 
profiled to determine the presence and quantity of known compounds. This was also done to 
establish if these solvents eluted a similar compound, or if the polarity of the solvents determined 
which compounds were extracted and the quantity thereof. The two solvents used were 96% EtOH 
and MeOH (view chapter 3 for process manufacturing details). Crude SCE-187-46208 is an EtOH 
extract and crude SCE-187-46222 is a MeOH extract. ECD provided two samples of dried plant 
material that were both extracted in EtOH. In addition, two ECD samples, commercially sourced 
Sceletium tortuosum capsules and a tincture were also chemically profiled as shown in Figure 4.12 
and Figure 4.14.  
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Figure 4.12: HPLC chemical profile of SCE-187-46208 (Ethanol extract). Showing the presence of mostly isolated and reported compounds of S. tortuosum 
with mesembrine being the major compound present in this sub-species. 
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Figure 4.13: HPLC chromatogram of Sceletium plant material (Patnala & Kanfer, 2010). 
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Figure 4.14: HPLC chemical profile of SCE-187-46222 (Methanol extract). Representing some of the commonly reported and isolated compounds of S. 
tortuosum. This spec shows more compounds isolated in the alkaloidal region as compared to that of EtOH extraction (Figure 4.12). View Figure 4.15 
bellow to view the spectral regions.
1 
2 
3 
4 
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The S. tortuosum methanol extract (SCE-187-46208) was analyzed using the same conditions 
discussed and as reflected in Table 3.1 (page 43) together with a PDA-UV detector for improved 
analysis. The abovementioned conditions separated ∆7mesembrenone (RT 17.29 min), 
mesembranol (RT 19.61), ∆4mesembrenone (RT 24.87 min), mesembrine (RT 31.67 min) and 
epimesembranol (RT 48.94 min) (Figure. 4.12). Due to high sample concentrations, the PDA-UV 
data of the methanol extract (SCE-187-46622) were not used. Instead, ESI MS data were used. In 
the ESI MS of the methanol extract, ∆7 mesembrenone was detected at 17.19 RT, while 
mesembranol eluted at 19.61 min and ∆4 mesembrenone in the ethanol extract detected at 24.94 
min. Mesembrine, on the other hand, presented in one broad peak and split into two peaks when 
integrated, this was due to the high concentration of the crude injected in the experimental run. An 
average retention time of the two peaks was 3.51 min. 
 
ECD provided two packs of dried plant material labelled only with sample numbers.  Samples TTSI-
MP-0013 and TTSI-MP-0015 were extracted in ethanol (5 hrs, Section 3.3.2 page 40) before 
profiling using HPLC. Once again, concentrating on the intermediate region (15.00 min – 40.00 
min) and a small part of the non-polar region of the HPLC chromatogram, the aim of the 
experiment was to identify major alkaloids present in the plants and to identify any similarities or 
differences between compounds within these plants, as well as the tincture, commercially available 
capsules or the experimental plant (the plant being phytochemically analyzed in this study).  It has 
been claimed that S. tortuosum has identified sub-species that can be differentiated at a molecular 
level by concentration and/or quantity of alkaloids or compounds present. The major alkaloid 
contained within the plant appears to belong within the 2a-aryl-cis-actehydroindole class 
(mesembrine type) (Section. 2.3). One explanation for this finding is that S. tortuosum has sub-
species that can only be differentiated by determining the alkaloids within the plant. Thus, not all S. 
tortuosum plants have mesembrine as their major compound and some plants within the species 
have ∆ 7mesembrenone, mesembranol, ∆ 4mesembrenone or epimesembranol as a major 
compound (Prof. A. Viljoen, (IPUF, 2011) (presentation and pers comm). It should be taken into 
consideration that levels of secondary plant metabolites, including the presence of alkaloids, are 
stongly infuenced by season, growing conditions and age of the plant.  
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Figure 4.15: HPLC profile of ECD dried plant material, TTSI-MP-0013 
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Figure 4.16: HPLC profile of ECD dried plant material, (TTSI-MP-0015). TSS-MP-0015 showed a similar compound profile as TSS-MP-0013 with 
epimesembranol being the major compound as compared to the laboratory profiled S. tortuosum which had mesembrine as its major compound.
3 
4 
1 
 
 
 
 
2 
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TTS-MP-0013 presented with epimesembranol (RT 48.50 min), mesembranol (RT 18.82 min), 
mesembrine (RT 31.30 min) and mesembrenone (RT 24.68 min). ∆7 Mesembrenone was detected 
at very low concentration compared to the other alkaloids present in this extract. TSS-MP-0015 
showed a similar compound profile with epimesembranol being the major compound (eluting at RT 
48.52 min). In this particular plant extract, mesembrenone (RT 24.73 min), together with 
mesembranol (RT 23.10 min), manifested at a slightly higher quantity when compared to 
mesembrine, which eluted at RT 31.34 min. ∆ 7 Mesembrenone was also present at a lower 
concentration and similar to TTSI-MP-0013.  
 
4.2.1 Profiling of Tincture 
It is reported that mesembrine, amongst other alkaloids, effects the central nervous system 
following intake of S. tortuosum. Based on this, tinctures of S. tortuosum and capsules are 
available in health shops to be ingested by individuals manifesting with stress, anxiety, depression 
and other mood-related conditions. A tincture as well as capsules (dried S. tortuosum plant 
material) were sourced and analyzed to identify if mesembrine was the main ingredient of the 
concoction. See Figures 4.17 and 4.18 (pages 79 and 80) for more details of results 
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Figure 4.17: HPLC PDA profile of a commercially available tincture. Used to investigate the constituent profile of one of the market available tinctures to 
determine which compounds are available in abundance resulting in the proclaimed properties. 
4 
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Figure 4.18: HPLC PDA profile of SCE-187-46289(commercially available capsules).
4 
3 
1 
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From the chromatogram spectrum (Figure 4.17), the tincture was a mixture of two compounds, 
with mesembrine being the major compound eluting at RT 31.42 min, while mesembrenone was 
found to be present at lower concentration and eluting at RT 24.79 min. Analysis of the 
chromatographic spectra of the Kanna capsule (SCE-187-46289 Figure 4.18) indicates that there 
are two minor and three major compounds present. Mesembrenone appears to be the major 
compound of this particular extract, eluting at RT 24.70 min, being present at a slightly higher 
concentration compared to mesembrine (eluting at RT 31. 32 min).In addition, there was also an 
unidentified compound suspected to be epimesembranol, which was observed at RT 50.94 min, 
being present in quantities higher than that of mesembrine. Again, it is possible that these 
compounds (mesembrenone and mesembrine) have the same health benefiting properties, as 
suggested by Smith et al., (1998). 
 
4.3 Plasmodium Lactate Dehydrogenase screening (pLDH): 
4.3.1 First round pLDH screening of Sceletium tortuosum: 
Vector resistance to synthetic insecticides, as well as and the hazardous environment resulting 
from contamination by toxic non-biodegradable residues resulting from these insecticides, calls for 
innovative strategies, including that of natural product usage, to control destructive disease-
causing vectors. In the latter instance,  extracts from herbal/medicinal plant material constitutes a 
rich source of biodegradable bioactive compounds which break down into non-toxic products, 
making them an ideal source for mosquito control measures (Elango et al., 2010). The genus 
Sceletium is rich in alkaloids, which constitute one of the most important classes of naturally 
occurring products for drug usage since ancient times. Although alkaloids have been successfully 
used to treat parasitic infections, extracts from Sceletium have not been sufficiently researched as 
a treatment for various ailments of biological importance (Kaur et al., 2009). 
 
In order to supplement  research performed on (extracts of) S. tortuosum by other workers, the 
approach taken in this study was focussed towards a possible outcome of using  this plant, or 
extracts thereof, for treatment  of selected medical conditions, such as malaria infection, or against 
the vector responsible for transmission of this disease. Due to the high quantity of alkaloids present 
in this plant, a Plasmodium lactate dehydrogenase (pLDH) biological assay was used to detect 
whether this plant showed any anti-malarial properties.   
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Table 4.7 shows the in vitro anti-malarial screening of 19 extracts from S. tortuosum. Activity from 
these samples ranged from 1.47 to >100 µg/ml. For an extract to be regarded as an active anti-
malarial, a resultant IC50 value of less than or equal to 10 µg/ml is required while any result greater 
than 10 µg/ml is considered non-active or a negative result. Of the 19 samples, four were found to 
be active. These are shown in red in Table 4.7. 
 
Table 4.11: IC50 of test samples from a screening assay of fermentation of S. tortuosum. 
 
 
 
 
.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Test sample IC50 (µg/ml 
1 SCE-187-46201A 37.96 
2 SCE-187-46201B >100 
3 SCE-187-46202A 12.10 
4 SCE-187-46202B 32.74 
5 SCE-187-46204A >100 
6 SCE-187-46204B 31.07 
7 SCE-187-46205A 1.50 
8 SCE-187-46205B 1.47 
9 SCE-187-46205FD 18.14 
10 SCE-187-46206A 19.94 
11 SCE-187-46206B 15.65 
12 SCE187-46207A 7.32 
13 SCE187-46207B 2.68 
14 SCE-187-46208 >100 
15 SCE-187-46208A 33.38 
16 SCE-187-46208B 32.28 
17 SCE-187-46222 69.18 
18 SCE-187-46223 >100 
19 SCE-187-46245 >100 
20 MeOH (Positive control) >100 
21 Blank-no drug (negative control) >100 
22 Reference strain – Cl 3D7 11.79 
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Samples were tested in triplicate while using chloroquine as a reference drug and MeOH as 
solvent control. Samples 7 and 8 (Table 4.7) were fermented in a conventional oven at 35oC for 6 
days, whereas samples 12 and 13 were fermented under natural conditions exposed to direct 
sunlight for 7 days. Sample 7 and 12 were both fermented in thermal bags, whereas sample 8 and 
13 were fermented in open trays.8,9 SCE-187-46208 and SCE-187-46222 were the extracts tested 
for biological activity, with the former being the EtOH extract and the latter being the MeOH extract. 
When reference to original plant specimen (SCE-187-46223) is made, isolated compounds from 
this material have been characterised as the compound mesembrine (see pages 55), while SCE-
187-46245 was similarly characterised as the compound pinitol (see pages 57). 
 
In contrast, extracts prepared from other plant material, such as specimen SCE187-46205, 
involved fermentation in an oven at constant temperature, and consistently gave very positive, low 
assay readings (1.50 and 1.47, respectively).  Similarly, the extracts prepared from specimen 
SCE187-46207, involved fermentation under varying temperature (day and night) in sunlight, 
resulting in positive, but varied, results (7.32 and 2.68, respectively). These results may support the 
hypothesis that particular plant specimens may require preparation at a relatively constant and high 
temperature, as experienced in the incubator, while the appropriate decomposition of other plant 
material may require various stresses, such as by varying temperature and duration of exposure 
time to sunlight.  
 
Another factor which needs to be taken into consideration, is dehydration of plant material during 
fermentation.  When organic material or any sample containing water is enclosed in a plastic bag 
and exposed to sunlight or heat, decomposition of the organic compounds may occur to a greater 
or lesser extent. As the specimens 7, 8, 12 and 13 were screened soon after receipt, these results 
support the observation that effective, medicinal use of S. tortuosum extracts are best achieved 
with fresh plant material. While significant results have been achieved in this study, there may be a 
number of additional (variable factors) that will contribute synergistically or antagonistically towards 
the isolation of a medically active compound.  As such, these results must be verified by further 
analysis.   
                                                          
8
 To view the preparation of test samples and standards go to Section 3.5.3.  
9
 To view what other samples are and how they were prepared and what the alphabet A and B stand for, please read Section 
3.2.2 – 3.2.2.1. 
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Samples showing a low IC50 result are indicated in Table 4.7. Figures 4.19, 4.20, 4.21, and 4.22 
indicate the HPLC profiles of Sceletium preparations (extracts dissolved in MeOH).The spectra 
above indicate commonly isolated alkaloids from this plant as ∆7 mesembrenone, mesembranol, ∆4 
mesembrenone and mesembrine. As such, it is very difficult to identify which of these compounds 
within these extracts is responsible for the anti-malarial activity, particularly as HPLC profiling of 
extracts from plant material which were negative for anti-malarial activity showed similar peaks as 
in the four profiles.
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Figure 4.19: HPLC profile of SCE-187-46205A associated with IC50 = 1.50µg/ml.  Showing a profile of one of the extracts that presented with excellent 
biological value suggesting that this extract could as well have anti-plasmodial properties.  This profile does not in any way show which compound is 
responsible for the observed activity. 
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Figure 4.20: HPLC profile of SCE-187-46205B associated withIC50 = 1.47 µg/ml 
1 3 
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Figure 4.21: HPLC profile of SCE-187-46207A associated with IC50 = 7.32µg/ml 
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1 
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Figure 4.22: HPLC profile of SCE-187-46207B associated with IC50 = 2.68 µg/ml 
1 
2 3 
4 
3 
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As far as Figures 4.19 to 4.22 are concerned, it might be the presence of other compounds in 
the extract that are responsible for the observed anti-malarial activity. Also note that the HPLC 
profiles of the four anti-malarial extracts shared similar peaks, particularly in the polar regions, 
but also in the non-polar regions of the chromatograms as well. Overall, no peak(s) appeared to 
be uniquely linked to anti-malarial activity. Although mesembrine appeared to be present in high 
quantities in all sample extracts tested, subsequent screening of this compound for biological 
activity did not show any anti-malarial properties. Alternatively, another compound/molecule 
may be attached to one or more of the compounds indicated in the HPLC profile, possibly 
forming a coordination complex with one of the above compounds. The proposed coordination 
complex may be destabilised during fermentation or during the extraction process prior to bio-
assaying. This explanation may be supported by a study done by Mbeunkui and colleagues 
(2012) involving the stem bark of Geissospermum vellosii, where it was concluded that the bark 
contained alkaloids associated with lead, which subsequently formed molecular structures that 
could together be responsible for their observed anti-malarial activity. 
 
As mentioned in section 4.1.4, mesembrine and other related compounds may be structurally 
and functionally labile, which prompted the need to rescreen the four anti-malarial samples 
(presented in Table 4.7).The extracts that were subsequently shown to have anti-malarial 
activity, were stored at 4oC in the cold room. These extracts were dissolved in (5 ml) DMSO as 
it was found that other extracts no longer completely dissolved in methanol. As with MeOH, 
DMSO was included as one of the controls in the bioassay. The results of this rescreening 
experiment are presented below in Figure 4.23 where the status of the compounds is indicated 
as “Freshly prepared”, “Old samples” and “Freeze dried”. The results of the anti-malarial activity 
of these extracts were compared to the original anti-malarial screening results and are 
presented on the same scale. The same procedure for plant material preparation was followed 
as previously described (Section 3.2.1). The originally active samples (SCE-187-46205A, SCE-
187-46205B, SCE-187-46207A and SCE-187-46207B) were stored at 4oC. These were also re-
tested for activity and are presented as “Old samples” in the Figure 4.23 below.  
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Due to the controversial results thus obtained, a stability test was designed and carried out, 
which lasted over a period of two months. The extracts were then chemically profiled, from the 
initial time of experiment, after a month of incubation at different temperatures and after 2 
months of incubation of storage, at a respective temperature. No plant extracts were screened 
for anti-malaria activity immediately after extraction. The plant material received from Parceval 
pharmaceuticals was dry ground plant material and therefore never identified before use, like 
that supplied by ECD. Extracts were divided into duplicates of 2g and placed at different 
temperatures. This was to see if there would be any changes in constituents of the extracts at 
different temperatures being 4 oC, -20 oC, +/
- 
25 oC, 35 oC, and 60 oC. For a summarised 
presentation of results, please view Appendix 40. 
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Chapter 5: 
Conclusion and recommendations 
5.1. Conclusion: 
This study complements previous studies on S. tortuosum carried out by Smith et al., (1996), 
Gericke & Viljoen (2008), Patnala & Kanfer (2009) and Shikanga et al., (2011) as well as 
several other researches. The abovementioned researchers extracted plant material from this 
species according to the traditional method of preparation, as mentioned in Chapter 1. Although 
the traditional method of preparation was followed in the present study, a few steps were 
adjusted to accommodate the conditions and location, where this process was taking place. For 
example, all steps were followed as described in Chapter 1, except that the plant material was 
not buried under ground, but was directly exposed to sun light. The aim of changing those steps 
was to optimize a scaled-up method of preparation/fermentation which differs somewhat from 
that used traditionally, but is still a reliable method to produce consistent results / effects and /or 
compounds of interest. 
 
It can be argued that this method of fermentation was successfully optimized, as compounds of 
interest were not compromised in the process. As discussed in Chapter 4, alkaloids of interest, 
similar to those described in the literature, were identified in all extracts, with each being 
analyzed and chemically profiled for various constituents using HPLC methodology. The results 
of this study were then compared to those of Patnala & Kanfer (2009), with commercial 
standards of S. tortuosum alkaloids being used as a reference when performing HPLC-based 
chemical profiling. According to the information gathered from the San people by Smith et al., 
(1996), it is believed that if not fermented, S. tortuosum will not possess ‘biologically active’ 
powers. It is assumed, that in this particular instance, they were referring to psychotic powers, 
as the San people believe this plant to have spiritually enhancing powers. It has also been 
noted, that unspecified mesembrenone and alkaloidal changes result from crushing and 
bruising of the plant material. Patnala and Kanfer (2009) stated that “the fermentation process 
undeniably transforms mesembrine to ∆7mesembrenone. This would obviously result in the 
degradation of mesembrine, when stored during and after fermentation. The same phenomenon 
where mesembrine quantities were observed to have decreased was observed during this study 
and also shown in the previously mentioned HPLC profiling results. Thus; it can confidently be 
concluded that, plant preparation and fermentation processes were successfully optimized.  
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Overall, it was found that various chromatographic techniques including TLC and CC that were, 
used in this study proved to be useful and reliable. Column chromatography (CC) was 
employed for the isolation of chemical constituents from the plant S. tortuosum. This method 
was considered a method of choice  by Smith et al., (1996) sixteen years ago and is still useful 
in this day and age, as proven by Shikanga et al., (2011) who successfully  used column 
chromatography, as well as other techniques, for the isolation of compounds from this species. 
 
Other chromatographic methods have proven to be better than others, especially where 
compound isolation is concerned.  In this regard, when compared to CC, preparative TLC 
proved to be very useful when it came to isolation of alkaloids.  In this study, compounds were 
isolated and purified by CC, which turned out to be time consuming. Preparative TLC was found 
to be tedious, but to be the best method for isolation of alkaloids from Sceletium as well as in 
the subsequent purification of compounds. Knowing which solvent system to use, for the 
isolation of a targeted alkaloid, was not only saved time but also proved to be beneficial in the 
long run.  
 
All four major alkaloids were successfully isolated and purified by both CC and prep-TLC. The 
compounds of this plant material were unfortunately found to be unstable, as discussed in 
Chapter 4. As all four alkaloids degraded and regrettably could not easily be re-accumulated, 
the ultimate acquisition of mesembrine and ∆4 mesembrenone thus obtained occurred with low 
yield. Sucrose and pinitol were isolated using CC, whereas obtusalin was isolated using prep-
TLC. Since no other phytochemical method was available, or had to be employed for the 
isolation and purification of the last of the four mentioned compounds, it was therefore 
concluded that the two methods were sufficiently reliable in this project for the isolation of 
compounds of S tortuosum. The confirmation of these isolated compounds depended on NMR 
spectroscopic results. Since all compounds isolated in this project were known and had 
previously been reported in the literature, only1H and 13C experiments were performed on 
purified plant extracts. The results were compared to those in literature as referenced in 
Chapter 4 and presented in the Appendices. NMR successfully validated the compounds thus 
isolated. 
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As stated by Marston (2007), HPLC is the best technique for an efficient separation of crude 
extracts and thus was a good technique to apply in this study. HPLC methodology played an 
important role in the confirmation of the presence of targeted alkaloids. Patnala & Kanfer, 
(2009) profiled the constituents of S. tortuosum, but due to the differences in geographical 
region, as well as differences in the harvesting season, a different method for HPLC profiling of 
S. tortuosumhad to be developed. Fortunately, the two researches used the same standards of 
alkaloids that were present in the species used in this project. As such, eluted compounds 
which were observed in the intermediate region of the chromatogram of this study, were similar 
to those presented by Patnala & Kanfer (2009), thereby not only corroborating the presence of 
the same compounds, but that this plant was indeed S. tortuosum and that the method 
developed was correctly optimised. 
 
HPLC was also used in the quantification10 of mesembrine (Appendix 41) after a ten day 
fermentation process. In addition, a laboratory isolated and purified mesembrine was used as a 
reference standard in this experiment. Smith et al., (1996) reported on the differential 
distribution of alkaloidal chemicals in the leaves (0.3%) and stem (0.86%) of S. tortuosum. 
Popelak & Lettengauer (1968) reported on the presence of mesembrine in “kougoed” 
(fermented S. tortuosum) to be around 0.7% in both leaves and stems of this plant. In this study, 
mesembrine was not quantified before fermentation, but the amount of mesembrine in plant 
material fermented in a thermal bag was found to be in agreement with the 0.7% quantity found 
in fermented S. tortuosum mesembrine material. Therefore, despite this plant being fermented 
under different conditions, compared to that of the traditional preparation and optimization of the 
method of preparation and fermentation was effective in agreement with values provided in 
literature. 
 
HPLC was then used for the evaluation of extracts set up for the stability test of S. tortuosum, 
as well as to track changes occurring in these extracts over time. The extracts were analytically 
profiled using HPLC before storage, after a month of storage and after two months of storage at 
different temperatures, as previously mentioned in Chapter 4. There were no major differences 
observed in the UV Diode Array spectra, but significant changes were observed in the ESI+ 
mode (Appendix 40, Figure i and ii), where it was noticed that there was a differential increase 
in the  concentration of some compounds at the expense of others. This differential trend was 
                                                          
10
  Summary of quantified mesembrine in samples fermented from the second batch (plant material stored at -20
o
C for six 
months) fermentation – Appendix 41. 
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observed throughout all the stored extracts, irrespective of the temperature of storage. This 
observation therefore supports the previously observed changes and confirms the notion that 
decomposition of certain alkaloids does in fact occur within the stored extracts over time. Table 
i. as well as Figure iv of Appendix 41 further  indicates the changes in the quantity of 
mesembrine in older crude material, originally extracted from the same plant batch (material). 
 
The isolation of the compound obtusalin was a highlight of this study, as no other triterpenoid, or 
structurally related compound has been reported in the literature to have ever been isolated 
from S. tortuosum, or the genus in general. Triterpenoids are generally very stable and, unlike 
the alkaloids of this plant material, do not decompose but were rather found in very low 
concentrations.  Since mesembrine was screened for anti-malarial properties and was found to 
be deficient of any activity, it might be assumed that other compounds unknown to this plant, 
like obtusalin could be responsible for some of the biological activity observed in this study. 
Since obtusalin was isolated at the latter stage of the study, it was not screened for anti-malarial 
activity; therefore; no such conclusion can be made at this stage. 
 
In essence, the isolation of this particular compound indicates that there are likely to be more 
compounds which still have to be discovered for the Sceletium genus, which might also have 
the potential for biological activity. 
 
5.2. Recommendations 
Significant compound decomposition in extracts was noticed after a period spent in storage. 
Extracts also seemed to develop two layers, where the oil separates from the extract paste. 
Constituent instability was also observed in the fresh (not dried) plant material stored at -20oC 
for six months. In this particular case, it is recommended that one should store plant material in 
a dried powder form, or as a dried whole plant. This will help preserve the plants constituents for 
however long is required. Extracts must be freeze-dried and stored in a temperature stable, dry 
and dark place, to prevent chemical changes.  It is also recommended that isolated compounds 
are dried before storage, to prevent them from breaking down. 
 
In retrospect, it would be wise to obtain the HPLC profiles of the fresh plant material before 
storage or usage, and then to compare or use as reference material in future experiments. 
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HPLC was used for the possible detection of compounds responsible for the activity observed 
from the pLDH screening assay results, but no specific compound was identified or connected 
with the observed activity. Thus, it is recommended, where future studies of this kind are 
planned, that a biological assay-guided fractionation approach be followed. In terms of 
phytochemistry, compounds of this plant tend to bond with silica and elutes slowly from silica  
columns. It is therefore advisable to always use 1% base (in this case Et2N) when isolating 
basic compounds and acetic acid when targeting very polar compounds as part of the solvent 
system.  
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APPENDICES 
 
Appendix 1: Harvesting details of Sceletiumtortuosum raw material by the CSIR 
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Appendix 2: Certificate of harvesting of Sceletiumtuortosum plant material. 
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Appendix 3: Part 2 of the certificate of harvesting of Sceletiumtortuosum plant material. 
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Appendix 4: SANBI plant identification certificate. 
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Appendix 5: Background on Malaria infection 
 
Background on Malaria Infection 
 
Malaria is one of the world’s deadliest diseases and is caused by the protozoan parasites 
belonging to the genus Plasmodium. There are four species known to account for almost all 
human infections thereby being responsible for most morbidity and mortality.  These are “P. 
falciparum, P. vivax, P. malariae, and P. ovale”, with P. falciparum being the commonest of the 
four human malaria parasites found across much of Africa especially sub-Saharan Africa 
(Greenwood et al., 2005). Malaria can be transmitted by several species of female anopheline 
mosquitoes that differ in behaviour, thus leading to various epidemiological patterns of the 
disease observed worldwide. Anophelise gambiae is the most common and widespread in 
Africa. P. vivax can develop in mosquitoes at a lower temperature than P. falciparum, hence its 
wider geographical range (Greenwood et al., 2005).  
 
Malaria is usually an endemic disease, but it may also occur as an outbreak. This may occur in 
areas with low seasonal transmission. There are several factors that may course outbreaks and 
these include an increase in vector breeding sites, migration of infected people into a vector-rich 
area, populated with susceptible individuals, arrival of new efficient vectors, breakdown of 
vector control measures, resistance of the parasites to treatment, and resistance of the vector to 
insecticides (Elango et al., 2010). The life cycle, immunological defence mechanisms and 
clinical development of malaria is complicated. This is reflected by aspects of clinical malaria 
that is characterized by periodic fever, which follows the lysis of infected erythrocytes, caused 
mainly by stimulation of cytokines interleukin-1 and tumor necrosis factor.  P. falciparum 
infection can have serious effects, for example, anaemia, cerebral complications (from coma to 
convulsion), hypoglycaemia and glomerulonephritis. The disease is most serious in non-
immune individuals, including children, pregnant women and tourists (Kauret al., 2009).  
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Malaria transmission 
Epidemiology 
Burden of disease 
 
Malaria is the world’s most important tropical disease.  It is prevalent in about 100 countries and 
is estimated that 247 million clinical episodes of malaria occur globally per annum, of which 
86% are in sub-Saharan Africa. More than 767 000 Africans were estimated to have died from 
malaria in 2008, and 88% were children under five years of age, equivalent to a child dying of 
malaria every 45 seconds (Bagavan et al., 2010 and Diapet al., 2010). Although most malarial-
associated deaths occur in Africa, evidence suggests that the number of clinical episodes of P. 
falciparum malaria is even higher than reported (including that due to P. vivax infections) and 
that morbidity due to malaria in Asia has been greatly under-estimated  (Greenwood et al., 
2005). In South East Asia alone, 100 million malaria cases occur every year and 70% of these 
are reported from India (Bagavan et al., 2010). 
 
In malaria-endemic areas, it is believed that malaria infections in pregnant women account for 
up to a quarter of all cases of severe maternal anaemia and for 10-20% of low birth weight in 
babies. In addition to its direct effect in infants, as based on its effect on birth weight, the 
disease could account for an additional 5-10% of neonatal and infant deaths. The effect of 
malaria extends far beyond the superficial measures and observation of mobility and mortality, 
and is associated with intellectual development impairment and persisting developmental 
abnormalities (Greenwood et al., 2005). 
 
Pathogenesis 
 
Malaria has a complex life cycle which consists of sexual and asexual phases. The sexual cycle 
occurs in mosquitoes and the asexual cycle takes place in the human host. The parasite 
depends on both hosts to complete its deadly life cycle. The parasite enters into the blood 
stream through injection as the mosquito bites the human host. The parasite starts reproducing 
rapidly in the liver. Some parasites lie dormant in the liver and become activated perhaps years 
after the initial infection has occurred. The parasite enters the bloodstream within 30 minutes, 
invades liver cells and starts to multiply.  They then lyse the liver cells and migrate to the 
bloodstream, where they attach and enter red blood cells and further reproduce. Infected red 
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blood cells lyse and allow the parasites to infect other blood cells and this becomes a 
continuous, and rapid, process in the blood stream.  
 
This repeating cycle depletes the body of oxygen and also causes fever and chills. After 
release, a dormant version of malaria travels through the host’s blood stream waiting to be 
ingested by another mosquito to carry it to a new host. Inside the mosquito itself, female and 
male sporozoites form a zygote-oocyte, cell division and multiplication takes place at a 
phenomenal rate. The zygote-oocytes migrate to the salivary gland and wait for re-infection to 
take place (JrSacciet al., 2006). 
 
Malaria life cycle             Source: http://dpd.cdc.gov/dpdx/html/Malaria.htm 
 
Malaria has an incubation period of around three weeks (seven to twenty one days). This is the 
period between the time the mosquito bites the human and the onset of the malaria illness. The 
initial time is somewhat unpredictable as reports suggest that the extent of incubation periods 
may range from four days to one year. Since some parasites remain dormant in the liver cells, 
the patient can relapse even after they have received treatment (Davis, 1996). 
 
 
Distribution 
Tropical diseases such as malaria have a serious impact on economic welfare and on public 
health problems in developing countries situated in the tropical belts of Asia, Africa and Latin 
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America and are less common in other parts of these continents (De Ridderet al., 2008 and 
Breman et al., 2004). Climatic conditions over a large part of Africa favour malaria transmission 
and global warming, together with changes in land use, are extending the areas of transmission 
(Pillay et al., 2008). Limpopo, KwaZulu Natal and Mpumalanga are the three provinces in South 
Africa to where malaria transmission is currently restricted. These provinces are situated in the 
north-eastern parts of the country along the borders of Mozambique and Swaziland. 
Transmission is associated with higher rainfall and an increase in temperature between 
September and May each year with a substantial inter-annual variation in the number of malaria 
cases. Low intensity seasonal transmission precludes the development of acquired immunity 
(Pillay et al., 2008 and Mehta et al., 2007).  
 
 
Global distribuiton map of malaria 
 
Malaria treatment 
The world’s first anti-malarial drug, quinine, was isolated in 1820 from Cinchona bark. 
Chloroquine, the most widely used anti-malarial drug was subsequently synthesized in 1940. 
The structure of a number of anti-malarial drugs are shown in Figure i. (a to i) below.  
Mefloquine (a) is one of the synthetic anti-malarial drugs with a mode of action similar to that of 
chloroquine. Primaquine (b) is given as a follow up drug after treatment with chloroquine to 
eradicate the liver hypnozoites of P. vivax and P. ovale.  Atovaquone (c) and proguanil (d) are 
used together to treat uncomplicated P. falciparum malaria whereas halofantrine (e) is 
administered in cases of uncomplicated multi-resistantP. falciparum malaria. Artemisinin (f) is 
 100 
 
an endoperoxide sesquiterpene lactone that was isolated from Chinese herb Artemisia annua in 
1972. Artemisinin and its derivatives are used for both uncomplicated and severe P. falciparum 
malaria. Derivatives most commonly used are artemisinin artemether (g), arte-ether (h) and 
artesunate (i) (Breman et al., 2004, Rosenthal, 2003 and Mital, 2007).  The chemical structures 
of these compounds are shown in Figure i. 
N
OH NH
CF3
CF3    
CH3
N
H3CO
NH2
 
 
 
O
O
OH
Cl
 
 
CF3
Cl
Cl
N CH3
CH3
OH  
 
 
NH NH NH CH3
CH3NHNHCH3
a.  Mefloquine b.  Primaquine 
c.  Atovaquone 
d.  Proguanil 
e.  Halofantrine 
 101 
 
O
O
O
CH3
CH3
CH3 O O
  
O
O
O
CH3
CH3
CH3 O O
CH3  
 
 
O
O
O
CH3
CH3
CH3 O O
CH3    
O
O
O
CH3
CH3
CH3 O O
CH3
O
O
  
 
 
Figure i: (a to i) Structures of anti-malarial drugs. 
 
Drug resistance 
Antimalarial drug resistance was defined as “the ability of a parasite strain to survive and/or 
multiply despite the administration and absorption of a drug given in doses equal to or higher 
than those usually recommended but within tolerance”. Resistance appears to occur through 
natural mutation that prompts reduced sensitivity to a given drug or class of drugs (Bloland, 
2001). Drug resistance was noticed in the late 1950’s and early 1960’s and expanded to 
become a worldwide problem. Multi-drug and extreme-drug resistance is a growing challenge in 
Africa and South-East Asia that resulted in a paradigm shift in the search for new and more 
effective anti-malarial drugs (Kian, 1995). Synergistic use of drugs has been useful, thus far, 
with some resistance being reported in recent years. Treatment combination reduces treatment 
failure, recrudescence and gametocyte carriage and increases drug efficacy. Resistance is also 
associated with reduced drug half-life, and, therefore, the longer the half-life of a drug, the 
f.   Artemisinin g.   Artemether 
h.   Arteether 
i.   Artesunate 
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greater are the chances that drug resistance development will be delayed (May and Meyer, 
2003).In all four malaria parasites that naturally infect humans, resistance to antimalarial drugs 
has been reported for only two species, P.  falciparum and P. vivax.  P. falciparum has 
developed resistance to nearly all antimalarials in current use, although the geographical 
distribution of resistance to any single antimalarial drug varies greatly. It has been shown that P. 
vivax infections acquired in some areas are resistant to chloroquine and/or primaquine. 
Sulfadoxine-pyrimethamine (SP) is becoming more prevalent in Africa and is increasingly being 
relied on as a replacement for chloroquine (Bloland, 2001).  
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Appendix 6: Mesembrine proton spectrum (processed using MestReNova software version 8). Refer to page 50 and page 54 to view 
the structure. 
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Appendix 7: Expansions of proton peaks fromt the mesembrine parameters (processed using MestReNova software version 8) 
 105 
 
 
 
 
Appendix 8: Mesembrine carbon 13 spectrum (processed using MestReNova software version 8). Refer to page 51 and page 54 to 
view the structure. 
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Appendix 9: ESI
+
 TOF mass spectrum of isolated mesembrine. Refer to page 52. 
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Appendix 10: UV absorption spectrum of Mesembrine detected in crude SCE-187-46208. Refer to page 53. 
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Appendix 6 Proton spectra of Pinitol (processed using: MestRaNova software version 8) Appendix 11: Proton spectra of pinitol (processed u ing MestReNova softwar  version 8). Refer to page 55 and page 56 to view the 
structure. 
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Appendix 7 Carbon 13 spectra of Pinitol (processed using: MestReNova software version 8) Appendix 12: Carbon 13 spectra of pinitol (processed usi g MestReNova software version 8). Refer to page 55 and page 56 to view the 
structure. 
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Appendix 1213: Laboratory isolated sucrose proton spectra with expansions (processed using MestReNova software version 8). Refer 
to page 57 and page 58 to view the structure. 
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Appendix 1314:Cormetial sucrose (table sugar) proton spectra with expansions (processed using MestReNova software version 8). Refer to 
page 57 and page 58 to view the structure. 
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Appendix 1415: Carbon 13 spectra of laboratory isolated sucrose (processed using MestReNova software version 8). Refer to page 
58 and page 58 to view the structure. 
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Appendix 1516: Carbon 13 spectra of comercial sucrose (table sugar) (processed using MestReNova software version 8). Refer to 
page 58 and page 58 to view the structure. 
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Appendix 1617:Mesembrenone proton spectrum (processed using MestReNova software version 8). Refer to page 60 and page 65 to 
view the structure. 
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Appendix 1718: Expansions of proton peaks from the mesembrenone parameters (processed using MestReNova software version 8) 
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Appendix 1819: Carbon 13 spectra of mesembrenone (processed using the MestReNova software version 8). Refer to page 61 and page 65 to 
view the structure. 
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Appendix 20: ESI
+
 TOF mass spectrum of isolated mesembrenone. Refer to page 63 and page 65 to view the structure. 
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Appendix 1921: LC-MS chromatogram of crushed plant material on day 10 MS IUon spectra of mesembrenone m/z 28802 (top). Refer to 
page 64. 
 119 
 
 
 
Appendix 2022: Obtusalin proton spectrum (processed using MestReNova software version 8). Refer to page 66 and page 66 to view the 
structure. 
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Appendix 2123: Expansions of proton peaks from the obtusalin parameters (processed using MestReNova software version 8) 
 
 121 
 
 
 
Appendix 2224: Carbon 13 spectra of obtusalin (processed using the MestReNova software version 8). Refer to page 66 and page 67 to view 
the structure. 
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Appendix 2325: Carbon 13 expansions of obtusalin (processed using the MestReNova software version 8) 
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Appendix 2426: HRTOFMS (ESI+) chromatogram of compound 5. Refer to page 69 and page 66 to view the structure. 
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Appendix 2527: HRTOFMS (ESI
+
) fragmentation of compound 5. Refer to page 70 and page 66 to view the structure. 
[M - C16H28O2 + (+OH) ]
 
[M – C13H26O2 +(+ 1H)] 
[M-CH14H24O2 + (+2H)] 
[M – C16H30O2 + (-2H)] 
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Appendix 28: HPLC chemical profile SCE-187-46208 (ethanol extract). Refer to page 72. 
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Appendix 2729: HPLC chromatogram of Sceletium plant material (Patnala&Kanfer, 2010). Refer to page 73. 
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Appendix 2830: HPLC chemical profile of SCE-187-46222 (methanol extract). Refer to page 74. 
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 Appendix 2931: HPLC chemical profile of ECD
+
dried plant material, TTSI-MP-0013. Refer to 76, discussed on page 75. 
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Appendix 3032: HPLC chemical profile of ECD+ dried plant material, TTSI-MP-0015. Refer to page 77, discussed in page 75.  
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Appendix 3133: HPLC PDA profile of a commercially available tincture. Refer to page 79, discussed in page 78. 
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Appendix 3234: HPLC PDA profile of a commercially available capsule (SCE-187-46289). Refer to page 80, discussed in page 
78.  
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Appendix 3335: HPLC profile of SCE-187-46205A associated with IC50 = 1.50µg/ml. Refer to page 85, discussion and table in pages 81-
88. 
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Appendix 3436: HPLC profile of SCE-187-46250B associated with IC50 = 1.47µg/ml. Refer to page 86, discussion and table in pages 81-
88. 
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Appendix 3537: HPLC profile of SCE-187-46207A associated with IC50 = 7.32µg/ml. Refer to page 87, discussion and table in pages 81-
88. 
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Appendix 3638: HPLC profile of SCE-187-46205B associated with IC50 = 2.68µg/ml. Refer to page 88, discussion and table in pages 81-
88. 
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 Appendix 3739: Results of rescreening for anti
storage at 4C compared 
 
Appendix 40: A summary of stabi
Summary of stability testing of 
As explained in chapter 4, this experiment 
this experiment was to see if there were any changes that were occurring within the extracts 
during the period of fermentation. Changes were trac
the constituents of the extracts and identify any changes be it an increase or decrease of 
compound concentrations or appearance of new peaks and disappearance of other peaks. 
Figure ii. represents UV chromatograms of a single extract (SCE
after extraction to the end of the experimental period (2 months). The bottom chromatogram has 
peaks higher in intensity, but the quantity of injection is the same as in the other tw
chromatograms. Figure i. represents the ESI
the UV chromatograms where no specific or particular changes were observed, it is evident that 
there are changes where some peaks seem to increase in intensity ov
seem to have disappeared or decreased resulting in a possible decomposition of certain 
compounds observed in the profile. 
0
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46205-A
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0
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l)
Comparison of screening results of the same 
sample after a period of time.
 
-malaria activity of samples 7, 8, 12 and 13 after 6 month's 
to the initial bioasay (in blue). Refer to page 90.
 
lity test procedure, results and background.
S. tortuosum constituents 
was carried out over a two month period
ked by using HPLC to chemically profile 
-187-46311
+
 of the same extract discussed above. Unlike in 
er time and some peaks 
46205-B 46207-A 46207-B
Sample numbers
First time screening
Freshly prepared
Old samples
Freeze dried
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. The aim of 
-A) from initial time 
o 
 Figure ii: ESI+mode results of an extract stored at 35
period. 
 
 
oC over a 2 month Figure iii: UV chromatogram of extract stored at 35 
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o
C over a two period of 
time. 
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Appendix 41: Below is a summarized table and bar graph of mesembrine quantification of second batch of 
fermented plant material (that stored at -20
o
C for six months) 
 
Table i: Comparison of mesembrine quantities in plant material freeze-dried and fermented in a thermal bag to 
those fermented in an open tray over a period of 10 day. 
Open tray fermentation % Mesembrine 
SCE-187-46269-A 1.7 
SCE-187-46269-B 1.7 
SCE-187-46269-C 2.5 
SCE-187-46269-D 2.4 
SCE-18746270-A 0.7 
SCE-18746270-B 1.1 
SCE-187-46270-C 1.9 
SCE-187-46270-D 2.4 
SCE-18746271-A 0.8 
SCE-18746271-B 1.4 
SCE-187-46271-C 1.5 
SCE-187-46271-D 1.3 
SCE-187-46272-A 0.5 
SCE-187-46272-B 2.1 
SCE-187-46272-C 1.4 
SCE-187-46272-D 1.6 
SCE-187-46273-A 0.8 
SCE-187-46273-B 0.3 
SCE-187-46271-C 1.6 
SCE-187-46271-D 1.7 
SCE-187-46275 freeze-dried 0.6 
 Figure iv: Mesembrine percentage detected in freeze
and open trays. (Plant material in retention).
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 in both thermal bags 
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